| 1304-5 | D Ab [Titer] in Serum or Plasma | D Ab |
| 52115-3 | D Ab [Presence] in Serum or Plasma by Antihuman globulin | D Ab |
| 973-8 | D Ab [Presence] in Serum or Plasma from Blood product unit | D Ab |
| 974-6 | D Ab [Presence] in Serum or Plasma from donor | D Ab |
| 975-3 | D Ab [Presence] in Serum or Plasma | D Ab |
| 1305-2 | D Ag [Presence] in Blood | D Ag |
| 976-1 | D Ag [Presence] on Red Blood Cells from Blood product unit | D Ag |
| 977-9 | D Ag [Presence] on Red Blood Cells from donor | D Ag |
| 978-7 | D Ag [Presence] on Red Blood Cells | D Ag |
| 979-5 | Di^a Ab [Presence] in Serum or Plasma from Blood product unit | D little i super little a Ab |
| 980-3 | Di^a Ab [Presence] in Serum or Plasma from donor | D little i super little a Ab |
| 981-1 | Di^a Ab [Presence] in Serum or Plasma | D little i super little a Ab |
| 982-9 | Di^a Ag [Presence] on Red Blood Cells from Blood product unit | D little i super little a Ag |
| 983-7 | Di^a Ag [Presence] on Red Blood Cells from donor | D little i super little a Ag |
| 984-5 | Di^a Ag [Presence] on Red Blood Cells | D little i super little a Ag |
| 985-2 | Di^b Ab [Presence] in Serum or Plasma from Blood product unit | D little i super little b Ab |
| 986-0 | Di^b Ab [Presence] in Serum or Plasma from donor | D little i super little b Ab |
| 987-8 | Di^b Ab [Presence] in Serum or Plasma | D little i super little b Ab |
| 988-6 | Di^b Ag [Presence] on Red Blood Cells from Blood product unit | D little i super little b Ag |
| 989-4 | Di^b Ag [Presence] on Red Blood Cells from donor | D little i super little b Ag |
| 990-2 | Di^b Ag [Presence] on Red Blood Cells | D little i super little b Ag |
| 991-0 | Do^a Ab [Presence] in Serum or Plasma from Blood product unit | D little o super little a Ab |
| 992-8 | Do^a Ab [Presence] in Serum or Plasma from donor | D little o super little a Ab |
| 993-6 | Do^a Ab [Presence] in Serum or Plasma | D little o super little a Ab |
| 994-4 | Do^a Ag [Presence] on Red Blood Cells from Blood product unit | D little o super little a Ag |
| 995-1 | Do^a Ag [Presence] on Red Blood Cells from donor | D little o super little a Ag |
| 996-9 | Do^a Ag [Presence] on Red Blood Cells | D little o super little a Ag |
| 967-0 | None | D little u Ab |
| 968-8 | None | D little u Ab |
| 969-6 | None | D little u Ab |
| 970-4 | Du Ag [Presence] on Red Blood Cells from Blood product unit | D little u Ag |
| 971-2 | Du Ag [Presence] on Red Blood Cells from donor | D little u Ag |
| 972-0 | Du Ag [Presence] on Red Blood Cells | D little u Ag |
| 1306-0 | D NOS Ab [Presence] in Serum or Plasma | D NOS Ab |
| 1307-8 | D NOS Ab [Presence] in Serum or Plasma from Blood product unit | D NOS Ab |
| 1308-6 | D NOS Ab [Presence] in Serum or Plasma from donor | D NOS Ab |
| 1309-4 | None | D NOS Ab |
| 1310-2 | D NOS Ag [Presence] on Red Blood Cells from Blood product unit | D NOS Ag |
| 1311-0 | D NOS Ag [Presence] on Red Blood Cells from donor | D NOS Ag |
| 1312-8 | D NOS Ag [Presence] on Red Blood Cells | D NOS Ag |
| 17997-8 | None | D-E excursion |
| 14045-9 | D-Lactate [Molecules/volume] in Serum or Plasma | D-lactate |
| 14046-7 | D-Lactate [Molecules/volume] in Urine | D-lactate |
| 44314-3 | D-Lactate/Creatinine [Molecular ratio] in Urine | D-lactate/Creatinine |
| 25899-6 | D-Lactate [Molecules/volume] in Serum or Plasma --1st specimen post excercise | D-Lactate^1st specimen post exercise |
| 25900-2 | D-Lactate [Molecules/volume] in Serum or Plasma --2nd specimen post excercise | D-Lactate^2nd specimen post exercise |
| 25901-0 | D-Lactate [Molecules/volume] in Serum or Plasma --3rd specimen post excercise | D-Lactate^3rd specimen post exercise |
| 25902-8 | D-Lactate [Molecules/volume] in Serum or Plasma --4th specimen post excercise | D-Lactate^4th specimen post exercise |
| 25903-6 | D-Lactate [Molecules/volume] in Serum or Plasma --5th specimen post excercise | D-Lactate^5th specimen post exercise |
| 25904-4 | D-Lactate [Molecules/volume] in Serum or Plasma --6th specimen post excercise | D-Lactate^6th specimen post exercise |
| 25905-1 | D-Lactate [Molecules/volume] in Serum or Plasma --Pre excercise | D-lactate^pre exercise |
| 13555-8 | D-pseudoephedrine [Presence] in Serum or Plasma | D-pseudoephedrine |
| 7791-7 | Dacrocytes [Presence] in Blood by Light microscopy | Dacryocytes |
| 19735-0 | None | Dactylis glomerata Ab.IgE |
| 6195-2 | Cocksfoot IgE Ab [Units/volume] in Serum | Dactylis glomerata Ab.IgE |
| 15746-1 | Cocksfoot IgE Ab RAST class in Serum | Dactylis glomerata Ab.IgE.RAST class |
| 25380-7 | None | Dactylis glomerata Ab.IgE.RAST class |
| 7365-0 | Cocksfoot IgG Ab [Units/volume] in Serum | Dactylis glomerata Ab.IgG |
| 7366-8 | Cocksfoot triggered histamine release [Units/volume] in Blood | Dactylis glomerata basophil bound Ab |
| 48263-8 | Cocksfoot triggered leukotriene release [Mass/volume] by Leukocytes | Dactylis glomerata leukotriene release |
| 7273-6 | Dahlia IgE Ab [Units/volume] in Serum | Dahlia sp Ab.IgE |
| 45449-6 | None | Daily animal companion &or presence |
| 45774-7 | None | Daily cleaning of teeth or dentures or mouth care by resident or staff |
| 45446-2 | None | Daily contact with relatives &or close friends |
| 41688-3 | Dalbavancin [Susceptibility] by Disk diffusion (KB) | Dalbavancin |
| 41689-1 | Dalbavancin [Susceptibility] by Minimum inhibitory concentration (MIC) | Dalbavancin |
| 41690-9 | Dalbavancin [Susceptibility] by Gradient strip (E-test) | Dalbavancin |
| 41734-5 | Dalbavancin [Susceptibility] | Dalbavancin |
| 9746-9 | Dantrolene [Mass/volume] in Serum or Plasma | Dantrolene |
| 3527-9 | Dantron [Mass/volume] in Urine | Dantron |
| 4208-5 | Dantron [Mass] of Dose | Dantron |
| 42665-0 | Dantron [Mass/mass] in Stool | Dantron |
| 10931-4 | Daphnia (fish feed) IgE Ab [Units/volume] in Serum | Daphnia Ab.IgE |
| 15677-8 | Daphnia (fish feed) IgE Ab RAST class in Serum | Daphnia Ab.IgE.RAST class |
| 51698-9 | Dapsone [Susceptibility] | Dapsone |
| 9747-7 | Dapsone [Mass/volume] in Serum or Plasma | Dapsone |
| 35787-1 | Daptomycin [Susceptibility] by Disk diffusion (KB) | Daptomycin |
| 35788-9 | Daptomycin [Susceptibility] by Minimum inhibitory concentration (MIC) | Daptomycin |
| 35789-7 | Daptomycin [Susceptibility] | Daptomycin |
| 41691-7 | Daptomycin [Susceptibility] by Gradient strip (E-test) | Daptomycin |
| 49666-1 | Darunavir [Susceptibility] by Phenotype method | Darunavir |
| 49630-7 | Darunavir+Ritonavir [Susceptibility] by Genotype method | Darunavir+Ritonavir |
| 35524-8 | None | Data handling and record keeping section |
| 46697-9 | None | Date |
| 45285-4 | Date & Time of Dose | Date & Time |
| 21932-9 | None | Date 1st cancer Rx (any).COC |
| 21931-1 | None | Date 1st cancer Rx (any).SEERS |
| 21927-9 | None | Date 1st chemotherapy treatment |
| 21928-7 | None | Date 1st hormone treatment |
| 21929-5 | None | Date 1st immunotherapy treatment |
| 39808-1 | None | Date 1st most definitive surgery Rx for |
| 21930-3 | None | Date 1st other treatment |
| 21919-6 | None | Date 1st positive Bx |
| 21926-1 | None | Date 1st radiation treatment |
| 21925-3 | None | Date 1st surgery treatment |
| 39809-9 | None | Date 1st systemic treatment |
| 30953-4 | None | Date and time of onset of vaccination adverse event |
| 49542-4 | Date and time of pheresis procedure | Date and time of pheresis procedure |
| 30952-6 | None | Date and time of vaccination |
| 46501-3 | None | Date assessment information completed |
| 18646-0 | Psychiatric rehabilitation treatment plan, date attending MD referred patient for treatment | Date attending MD referred patient for |
| 27492-8 | Alcohol-substance abuse rehabilitation treatment plan, date attending MD referred patient for treatment | Date attending MD referred patient for |
| 27540-4 | Cardiac rehabilitation treatment plan, date attending MD referred patient for treatment | Date attending MD referred patient for |
| 27562-8 | Skilled nursing treatment plan, date attending MD referred patient for treatment | Date attending MD referred patient for |
| 27613-9 | Occupational therapy treatment plan, date attending MD referred patient for treatment | Date attending MD referred patient for |
| 27676-6 | Physical therapy treatment plan, date attending MD referred patient for treatment | Date attending MD referred patient for |
| 27715-2 | Respiratory therapy treatment plan, date attending MD referred patient for treatment | Date attending MD referred patient for |
| 27766-5 | Medical social services treatment plan, date attending MD referred patient for treatment | Date attending MD referred patient for |
| 29172-4 | Speech therapy treatment plan, date attending MD referred patient for treatment | Date attending MD referred patient for |
| 18647-8 | Psychiatric rehabilitation treatment plan, date attending MD signed | Date attending MD signed |
| 27493-6 | Alcohol-substance abuse rehabilitation treatment plan, date responsible attending md signed | Date attending MD signed |
| 27541-2 | Cardiac rehabilitation treatment plan, date attending MD signed | Date attending MD signed |
| 27563-6 | Skilled nursing treatment plan, date attending MD signed | Date attending MD signed |
| 27614-7 | Occupational therapy treatment plan, date attending MD signed | Date attending MD signed |
| 27677-4 | Physical therapy treatment plan, date attending MD signed | Date attending MD signed |
| 27716-0 | Respiratory therapy treatment plan, date attending MD signed | Date attending MD signed |
| 27767-3 | Medical social services treatment plan, date attending MD signed | Date attending MD signed |
| 29173-2 | Speech therapy treatment plan, date attending MD signed | Date attending MD signed |
| 52156-7 | None | Date attending MD signed |
| 45427-2 | None | Date background information form completed |
| 52116-1 | Date blood unit received | Date blood product unit received |
| 22005-3 | None | Date case completed |
| 22006-1 | None | Date case last changed |
| 22007-9 | None | Date case report exported |
| 22009-5 | None | Date case report loaded |
| 22008-7 | None | Date case report received |
| 47241-5 | None | Date determined medically eligible and ready to start HIV Rx |
| 47240-7 | None | Date determined medically eligible to start HIV Rx |
| 45257-3 | None | Date dropped from HIV Rx |
| 45234-2 | None | Date eligible and selected to start HIV Rx |
| 29191-4 | Speech therapy treatment plan, plan end date | Date end |
| 21854-5 | None | Date first Dx |
| 30947-6 | None | Date form completed |
| 46636-7 | None | Date form completed |
| 21975-8 | None | Date last contact |
| 29742-4 | Date last dose | Date last dose |
| 8665-2 | None | Date last menstrual period |
| 21863-6 | None | Date last screened |
| 45237-5 | None | Date lost to HIV Rx follow-up |
| 45238-3 | None | Date lost to HIV Rx therapy |
| 45354-8 | None | Date next dose |
| 39161-5 | None | Date next screen visit |
| 21933-7 | None | Date non cancer directed surgery Rx as part of 1st cancer |
| 45353-0 | Date of analysis of unspecified specimen | Date of analysis |
| 53665-6 | None | Date of best overall gestational age estimate |
| 42029-9 | None | Date of conclusive diagnosis |
| 31211-6 | None | Date of death |
| 53719-1 | None | Date of death - Canada |
| 42031-5 | None | Date of diagnosis of multiple tumors |
| 50786-3 | None | Date of entry |
| 21870-1 | None | Date of inpatient admission |
| 21871-9 | None | Date of inpatient discharge |
| 45453-8 | None | Date of last day of MDS observation period |
| 46581-5 | None | Date of last home visit |
| 18654-4 | Psychiatric rehabilitation treatment plan, date of last plan of treatment certification | Date of last plan of treatment certification |
| 27501-6 | Alcohol-substance abuse rehabilitation treatment plan, date of last plan of treatment certification | Date of last plan of treatment certification |
| 27548-7 | Cardiac rehabilitation treatment plan, date of last plan of treatment certification | Date of last plan of treatment certification |
| 27570-1 | Skilled nursing treatment plan, date of last plan of treatment certification | Date of last plan of treatment certification |
| 27621-2 | Occupational therapy treatment plan, date of last plan of treatment certification | Date of last plan of treatment certification |
| 27684-0 | Physical therapy treatment plan, date of last plan of treatment certification | Date of last plan of treatment certification |
| 27723-6 | Respiratory therapy treatment plan, date of last plan of treatment certification | Date of last plan of treatment certification |
| 27774-9 | Medical social services treatment plan, date of last plan of treatment certification | Date of last plan of treatment certification |
| 29180-7 | Speech therapy treatment plan, date of last plan of treatment certification | Date of last plan of treatment certification |
| 18670-0 | None | Date of next planned rehabilitation treatment |
| 30907-0 | Alcohol-substance abuse treatment plan, date range (from/through) of next planned treatment (composite) | Date of next planned rehabilitation treatment |
| 31035-9 | None | Date of other vaccinations given within 4 weeks prior to the date of vaccine causing adverse event |
| 53663-1 | None | Date of prior gestational age estimate |
| 45455-3 | None | Date of reentry to facility |
| 45351-4 | Date of skin test | Date of skin test |
| 42117-2 | None | Date of surgical discharge |
| 45376-1 | Date of transfusion reaction | Date of transfusion reaction |
| 52584-0 | None | Date of ulcer measurement |
| 30944-3 | None | Date of vaccination temporary contraindication &or precaution expiration |
| 30573-0 | None | Date of wound healing |
| 45235-9 | None | Date original clinic HIV Rx start |
| 52082-5 | Alcohol-substance abuse rehabilitation treatment plan, referral information - date patient referred for treatment | Date patient referred for treatment |
| 52153-4 | None | Date patient referred for treatment |
| 52195-5 | None | Date patient referred for treatment |
| 52222-7 | None | Date patient referred for treatment |
| 52269-8 | None | Date patient referred for treatment |
| 52277-1 | None | Date patient referred for treatment |
| 52308-4 | None | Date patient referred for treatment |
| 52339-9 | None | Date patient referred for treatment |
| 52362-1 | None | Date patient referred for treatment |
| 52389-4 | None | Date patient referred for treatment |
| 39255-5 | None | Date previous screen visit |
| 42120-6 | None | Date radiation ended |
| 18642-9 | Psychiatric rehabilitation treatment plan, date range (from/through) of hospitalization leading to treatment (composite) | Date range |
| 27490-2 | Alcohol-substance abuse rehabilitation treatment plan, date range (from/through) of hospitalization leading to treatment (composite) | Date range |
| 27536-2 | Cardiac rehabilitation treatment plan, date range (from/through) of hospitalization leading to treatment (composite) | Date range |
| 27560-2 | Skilled nursing treatment plan, date range (from/through) of hospitalization leading to treatment (composite) | Date range |
| 27611-3 | Occupational therapy treatment plan, date range (from/through) of hospitalization leading to treatment (composite) | Date range |
| 27674-1 | Physical therapy treatment plan, date range (from/through) of hospitalization leading to treatment (composite) | Date range |
| 27713-7 | Respiratory therapy treatment plan, date range (from/through) of hospitalization leading to treatment (composite) | Date range |
| 27764-0 | Medical social services treatment plan, date range (from/through) of hospitalization leading to treatment (composite) | Date range |
| 29203-7 | Speech therapy treatment plan, date range (from/through) of hospitalization leading to treatment (composite) | Date range |
| 52076-7 | Alcohol-substance abuse rehabilitation treatment plan, date range of treatment | Date range |
| 52077-5 | Alcohol-substance abuse rehabilitation treatment plan, date range (from/through) of hospitalization leading to treatment | Date range |
| 52140-1 | None | Date range |
| 52147-6 | None | Date range |
| 52189-8 | None | Date range |
| 52190-6 | None | Date range |
| 52216-9 | None | Date range |
| 52217-7 | None | Date range |
| 52243-3 | None | Date range |
| 52271-4 | None | Date range |
| 52272-2 | None | Date range |
| 52301-9 | None | Date range |
| 52303-5 | None | Date range |
| 52333-2 | None | Date range |
| 52334-0 | None | Date range |
| 52356-3 | None | Date range |
| 52357-1 | None | Date range |
| 52383-7 | None | Date range |
| 52384-5 | None | Date range |
| 52413-2 | None | Date range |
| 18639-5 | Psychiatric rehabilitation treatment plan, date range (from/through) described by plan (composite) | Date range (from_through) described by plan |
| 27487-8 | Alcohol-substance abuse rehabilitation treatment plan, date range (from/through) described by plan (composite) | Date range (from_through) described by plan |
| 27533-9 | Cardiac rehabilitation treatment plan, date range (from/through) described by plan (composite) | Date range (from_through) described by plan |
| 27557-8 | Skilled nursing treatment plan, date range (from/through) described by plan (composite) | Date range (from_through) described by plan |
| 27608-9 | Occupational therapy treatment plan, date range (from/through) described by plan (composite) | Date range (from_through) described by plan |
| 27671-7 | Physical therapy treatment plan, date range (from/through) described by plan (composite) | Date range (from_through) described by plan |
| 27710-3 | Respiratory therapy treatment plan, date range (from/through) described by plan (composite) | Date range (from_through) described by plan |
| 27761-6 | Medical social services treatment plan, date range (from/through) described by plan (composite) | Date range (from_through) described by plan |
| 29170-8 | Speech therapy treatment plan, date range (from/through) described by plan (composite) | Date range (from_through) described by plan |
| 52088-2 | Alcohol-substance abuse rehabilitation treatment plan, date range certifying the plan of care | Date range certifying the plan of care |
| 52167-4 | None | Date range certifying the plan of care |
| 52200-3 | None | Date range certifying the plan of care |
| 52227-6 | None | Date range certifying the plan of care |
| 52251-6 | None | Date range certifying the plan of care |
| 52282-1 | None | Date range certifying the plan of care |
| 52316-7 | None | Date range certifying the plan of care |
| 52344-9 | None | Date range certifying the plan of care |
| 52367-0 | None | Date range certifying the plan of care |
| 52394-4 | None | Date range certifying the plan of care |
| 52106-2 | Alcohol-substance abuse rehabilitation treatment plan, date range (from/through) of next planned treatment | Date range of next planned treatment |
| 30976-5 | None | Date received |
| 49548-1 | Date reference lab test sent | Date reference lab test sent |
| 18648-6 | Psychiatric rehabilitation treatment plan, date rehab professional signed | Date rehabilitation professional signed |
| 27494-4 | Alcohol-substance abuse rehabilitation treatment plan, date rehabilitation professional signed | Date rehabilitation professional signed |
| 27542-0 | Cardiac rehabilitation treatment plan, date cardiac rehabilitation professional signed | Date rehabilitation professional signed |
| 27564-4 | Skilled nursing treatment plan, date skilled nursing professional signed | Date rehabilitation professional signed |
| 27615-4 | Occupational therapy treatment plan, date occupational therapy professional signed | Date rehabilitation professional signed |
| 27678-2 | Physical therapy treatment plan, date physical therapy professional signed | Date rehabilitation professional signed |
| 27717-8 | Respiratory therapy treatment plan, date respiratory therapy professional signed | Date rehabilitation professional signed |
| 27768-1 | Medical social services treatment plan, date medical social services professional signed | Date rehabilitation professional signed |
| 29175-7 | Speech therapy treatment plan, date speech therapy professional signed | Date rehabilitation professional signed |
| 52159-1 | None | Date rehabilitation professional signed |
| 45355-5 | Date RhoGam given | Date RhoGam given |
| 45352-2 | Date skin test interpreted | Date skin test interpreted |
| 29164-1 | Speech therapy treatment plan, start date | Date start |
| 42781-5 | None | Date surgery |
| 45348-0 | Date tick acquired | Date tick acquired |
| 45347-2 | Date tick attached | Date tick attached |
| 45346-4 | Date tick removed | Date tick removed |
| 22010-3 | None | Date tumor record available |
| 34970-4 | Ultrasoiund date | Date ultrasound |
| 30980-7 | None | Date vaccine due |
| 29769-7 | None | Date vaccine information statement presented |
| 29768-9 | None | Date vaccine information statement published |
| 18641-1 | Rehabilitation treatment plan, plan end date | Date.end |
| 27489-4 | Alcohol-substance abuse rehabilitation treatment plan, plan end date | Date.end |
| 27535-4 | Cardiac rehabilitation treatment plan, plan end date | Date.end |
| 27559-4 | Skilled nursing treatment plan, plan end date | Date.end |
| 27610-5 | Occupational therapy treatment plan, plan end date | Date.end |
| 27673-3 | Physical therapy treatment plan, plan end date | Date.end |
| 27712-9 | Respiratory therapy treatment plan, plan end date | Date.end |
| 27763-2 | Medical social services treatment plan, plan end date | Date.end |
| 18627-0 | Psychiatric rehabilitation treatment plan, date onset or exacerbation of primary diagnosis | Date.onset or exacerbation |
| 27471-2 | Skilled nursing treatment plan, date onset or exacerbation of primary diagnosis | Date.onset or exacerbation |
| 27484-5 | Cardiac rehabilitation treatment plan, date onset or exacerbation of primary diagnosis | Date.onset or exacerbation |
| 27598-2 | Occupational therapy treatment plan, date onset or exacerbation of primary diagnosis | Date.onset or exacerbation |
| 27661-8 | Physical therapy treatment plan, date onset or exacerbation of primary diagnosis | Date.onset or exacerbation |
| 27700-4 | Respiratory therapy treatment plan, date onset or exacerbation of primary diagnosis | Date.onset or exacerbation |
| 27751-7 | Medical social services treatment plan, date onset or exacerbation of primary diagnosis | Date.onset or exacerbation |
| 27801-0 | Alcohol-substance abuse rehabilitation treatment plan, date onset or exacerbation of primary diagnosis | Date.onset or exacerbation |
| 29163-3 | Speech therapy treatment plan, date onset or exacerbation of primary diagnosis | Date.onset or exacerbation |
| 52139-3 | None | Date.onset or exacerbation |
| 18628-8 | Psychiatric rehabilitation treatment plan, start date | Date.start |
| 27472-0 | Skilled nursing treatment plan, start date | Date.start |
| 27475-3 | Alcohol-substance abuse rehabilitation treatment plan, start date | Date.start |
| 27485-2 | Cardiac rehabilitation treatment plan, start date | Date.start |
| 27599-0 | Occupational therapy treatment plan, start date | Date.start |
| 27662-6 | Physical therapy treatment plan, start date | Date.start |
| 27701-2 | Respiratory therapy treatment plan, start date | Date.start |
| 27752-5 | Medical social services treatment plan, start date | Date.start |
| 30946-8 | None | Date.vaccination contraindication &or precaution effective |
| 42900-1 | Carrot IgE Ab [Ratio] in Serum | Daucus carota Ab.IgE |
| 6061-6 | Carrot IgE Ab [Units/volume] in Serum | Daucus carota Ab.IgE |
| 15605-9 | Carrot IgE Ab RAST class in Serum | Daucus carota Ab.IgE.RAST class |
| 7180-3 | Carrot IgG Ab [Units/volume] in Serum | Daucus carota Ab.IgG |
| 21145-8 | Carrot IgG Ab RAST class in Serum | Daucus carota Ab.IgG.RAST class |
| 7181-1 | Carrot triggered histamine release [Units/volume] in Blood | Daucus carota basophil bound Ab |
| 48210-9 | Carrot triggered leukotriene release [Mass/volume] by Leukocytes | Daucus carota leukotriene release |
| 28377-0 | None | Day sweats |
| 46058-4 | None | Days received the following medication |
| 47027-8 | DBA44 Ag [Presence] in Tissue by Immune stain | DBA44 Ag |
| 1000-9 | DBG Ab [Presence] in Serum or Plasma from Blood product unit | DBG Ab |
| 1001-7 | DBG Ab [Presence] in Serum or Plasma from donor | DBG Ab |
| 1002-5 | DBG Ab [Presence] in Serum or Plasma | DBG Ab |
| 997-7 | DBG Ag [Presence] on Red Blood Cells from Blood product unit | DBG Ag |
| 998-5 | DBG Ag [Presence] on Red Blood Cells from donor | DBG Ag |
| 999-3 | DBG Ag [Presence] on Red Blood Cells | DBG Ag |
| 44673-2 | None | DCIS.uninvolved margin distance.closest |
| 44675-7 | None | DCIS.uninvolved margin.closest |
| 48969-0 | DCX gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Narrative | DCX gene mutation analysis |
| 22019-4 | None | Death certificate number |
| 42672-6 | Debris [Presence] in Semen | Debris |
| 45769-7 | None | Debris - soft, easily movable substances - present in mouth prior to going to bed at night |
| 13726-5 | Decadienediate/Creatinine [Mass ratio] in Urine | Decadienediate/Creatinine |
| 25093-6 | Decadienediate/Creatinine [Molecular ratio] in Urine | Decadienediate/Creatinine |
| 53180-6 | Decadienoylcarnitine (C10:2) [Molecules/volume] in Blood dot (filter paper) | Decadienoylcarnitine (C10:2) |
| 53459-4 | Decadienoylcarnitine (C10:2) [Molecules/volume] in Amniotic Fluid | Decadienoylcarnitine (C10:2) |
| 53464-4 | Decadienoylcarnitine (C10:2) [Molecules/volume] in Cerebral spinal fluid | Decadienoylcarnitine (C10:2) |
| 53471-9 | Decadienoylcarnitine (C10:2) [Molecules/volume] in Serum or Plasma | Decadienoylcarnitine (C10:2) |
| 53492-5 | Decadienoylcarnitine (C10:2) [Molecules/volume] in Urine | Decadienoylcarnitine (C10:2) |
| 53508-8 | Decadienoylcarnitine (C10:2) [Molecular ratio] in Urine | Decadienoylcarnitine (C10:2) |
| 35146-0 | Decanoate (C10:0) [Molecules/volume] in Serum or Plasma | Decanoate |
| 47613-5 | Decanoate (C10:0)/Creatinine [Molecular ratio] in Urine | Decanoate/Creatinine |
| 18452-3 | Decanoylcarnitine (C10) [Mass/volume] in Serum or Plasma | Decanoylcarnitine (C10) |
| 30327-1 | Decanoylcarnitine (C10) [Molecules/volume] in Serum or Plasma | Decanoylcarnitine (C10) |
| 45197-1 | Decanoylcarnitine (C10) [Molecules/volume] in Blood dot (filter paper) | Decanoylcarnitine (C10) |
| 53056-8 | Decanoylcarnitine (C10) [Molecules/volume] in Amniotic Fluid | Decanoylcarnitine (C10) |
| 53075-8 | Decanoylcarnitine (C10) [Molecules/volume] in Cerebral spinal fluid | Decanoylcarnitine (C10) |
| 53102-0 | Decanoylcarnitine (C10) [Molecules/volume] in Urine | Decanoylcarnitine (C10) |
| 53504-7 | Decanoylcarnitine (C10)/Creatinine [Molecular ratio] in Urine | Decanoylcarnitine (C10)/Creatinine |
| 53208-5 | Decatrienoylcarnitine (C10:3) [Molecules/volume] in Blood dot (filter paper) | Decatrienoylcarnitine (C10:3) |
| 17998-6 | None | Deceleration |
| 17999-4 | None | Deceleration |
| 18000-0 | None | Deceleration |
| 20176-4 | None | Deceleration |
| 20217-6 | None | Deceleration |
| 20218-4 | None | Deceleration |
| 20283-8 | None | Deceleration |
| 20219-2 | None | Deceleration 2 |
| 18002-6 | None | Deceleration slope |
| 20175-6 | None | Deceleration slope |
| 20216-8 | None | Deceleration slope |
| 20282-0 | None | Deceleration slope |
| 20345-5 | None | Deceleration slope |
| 18003-4 | None | Deceleration time slope |
| 20215-0 | None | Deceleration.max |
| 20275-4 | None | Deceleration.pressure half-time |
| 18001-8 | None | Deceleration.pressure.half time |
| 20220-0 | None | Deceleration.XXX/Deceleration 2.XXX |
| 13727-3 | Decenediate/Creatinine [Mass ratio] in Urine | Decenediate/Creatinine |
| 25094-4 | Decenediate/Creatinine [Molecular ratio] in Urine | Decenediate/Creatinine |
| 35147-8 | Decenoate (C10:1) [Molecules/volume] in Serum or Plasma | Decenoate |
| 47614-3 | Decenoate (C10:1)/Creatinine [Molecular ratio] in Urine | Decenoate/Creatinine |
| 30328-9 | Decenoylcarnitine (C10:1) [Molecules/volume] in Serum or Plasma | Decenoylcarnitine (C10:1) |
| 45198-9 | Decenoylcarnitine (C10:1) [Molecules/volume] in Blood dot (filter paper) | Decenoylcarnitine (C10:1) |
| 53057-6 | Decenoylcarnitine (C10:1) [Molecules/volume] in Amniotic Fluid | Decenoylcarnitine (C10:1) |
| 53076-6 | Decenoylcarnitine (C10:1) [Molecules/volume] in Cerebral spinal fluid | Decenoylcarnitine (C10:1) |
| 53103-8 | Decenoylcarnitine (C10:1) [Molecules/volume] in Urine | Decenoylcarnitine (C10:1) |
| 53108-7 | Decenoylcarnitine (C10:1)/Creatinine [Molecular ratio] in Urine | Decenoylcarnitine (C10:1)/Creatinine |
| 16151-3 | Dechlorane [Presence] in Serum or Plasma | Dechlorane |
| 16720-5 | Dechlorane [Presence] in Blood | Dechlorane |
| 52687-1 | None | Decision authority documented |
| 28086-7 | None | Decisional conflict |
| 32389-9 | None | Deep tendon reflex |
| 32390-7 | None | Deep tendon reflex |
| 32391-5 | None | Deep tendon reflex |
| 32392-3 | None | Deep tendon reflex |
| 32393-1 | None | Deep tendon reflex |
| 32491-3 | None | Deep tendon reflex |
| 45642-6 | None | Deep vein thrombosis |
| 10926-4 | Deer epithelium IgE Ab [Units/volume] in Serum | Deer epithelium Ab.IgE |
| 15679-4 | Deer epithelium IgE Ab RAST class in Serum | Deer epithelium Ab.IgE.RAST class |
| 11169-0 | Deer hair IgE Ab [Units/volume] in Serum | Deer hair Ab.IgE |
| 21238-1 | Deer hair IgE Ab RAST class in Serum | Deer hair Ab.IgE.RAST class |
| 18004-2 | None | Defect.diameter |
| 18005-9 | None | Defect.diameter |
| 18008-3 | None | Defect.gradient.systole.max |
| 18009-1 | None | Defect.gradient.systole.mean |
| 29461-1 | None | Defect.velocity.systole.max |
| 28087-5 | None | Defensive coping |
| 52266-4 | None | Defined school year |
| 52297-9 | None | Defined school year |
| 52409-0 | None | Defined school year |
| 45246-6 | None | Degree of adherence to anti-retroviral drug regimen |
| 45245-8 | None | Degree of adherence to cotrimoxzole |
| 45696-2 | None | Dehydrated |
| 45911-5 | None | Dehydration &or fluid maintenance trigger |
| 31013-6 | Dehydrochlormethyltestosterone [Mass/volume] in Urine | Dehydrochlormethyltestosterone |
| 13612-7 | Dehydroepiandrosterone [Mass/time] in 24 hour Urine | Dehydroepiandrosterone |
| 15054-0 | Dehydroepiandrosterone [Molecules/volume] in Serum or Plasma | Dehydroepiandrosterone |
| 2193-1 | Dehydroepiandrosterone [Mass/volume] in Serum or Plasma | Dehydroepiandrosterone |
| 2194-9 | Dehydroepiandrosterone [Presence] in Urine | Dehydroepiandrosterone |
| 2195-6 | Dehydroepiandrosterone [Mass/volume] in Urine | Dehydroepiandrosterone |
| 25391-4 | Dehydroepiandrosterone [Molecules/time] in 24 hour Urine | Dehydroepiandrosterone |
| 25895-4 | Dehydroepiandrosterone [Molecules/volume] in 24 hour Urine | Dehydroepiandrosterone |
| 30029-3 | Dehydroepiandrosterone [Units/volume] in Saliva | Dehydroepiandrosterone |
| 31020-1 | Dehydroepiandrosterone [Mass/volume] in Amniotic Fluid | Dehydroepiandrosterone |
| 34279-0 | Dehydroepiandrosterone [Molecules/volume] in Urine | Dehydroepiandrosterone |
| 35206-2 | Dehydroepiandrosterone [Mass or Molecules/volume] in Serum or Plasma | Dehydroepiandrosterone |
| 49716-4 | Dehydroepiandrosterone [Mass/volume] in Saliva | Dehydroepiandrosterone |
| 14688-6 | Dehydroepiandrosterone sulfate [Molecules/volume] in Serum or Plasma | Dehydroepiandrosterone sulfate |
| 15053-2 | Dehydroepiandrosterone sulfate [Molecules/time] in 24 hour Urine | Dehydroepiandrosterone sulfate |
| 16721-3 | Dehydroepiandrosterone sulfate [Mass/volume] in Saliva | Dehydroepiandrosterone sulfate |
| 2190-7 | Dehydroepiandrosterone sulfate [Mass/volume] in Amniotic Fluid | Dehydroepiandrosterone sulfate |
| 2191-5 | Dehydroepiandrosterone sulfate [Mass/volume] in Serum or Plasma | Dehydroepiandrosterone sulfate |
| 2192-3 | Dehydroepiandrosterone sulfate [Mass/time] in 24 hour Urine | Dehydroepiandrosterone sulfate |
| 34280-8 | Dehydroepiandrosterone sulfate [Molecules/volume] in Urine | Dehydroepiandrosterone sulfate |
| 34281-6 | Dehydroepiandrosterone sulfate [Molecules/volume] in 24 hour Urine | Dehydroepiandrosterone sulfate |
| 35205-4 | Dehydroepiandrosterone sulfate [Mass or Molecules/volume] in Serum or Plasma | Dehydroepiandrosterone sulfate |
| 34282-4 | Dehydroepiandrosterone sulfate/Creatinine [Molecular ratio] in Urine | Dehydroepiandrosterone sulfate/Creatinine |
| 16722-1 | Dehydroepiandrosterone sulfate [Mass/volume] in Serum or Plasma --10th specimen post XXX challenge | Dehydroepiandrosterone sulfate^10th specimen post XXX challenge |
| 49888-1 | Dehydroepiandrosterone sulfate [Mass/volume] in Serum or Plasma --1 hour post dose corticotropin | Dehydroepiandrosterone sulfate^1H post dose corticotropin |
| 16723-9 | Dehydroepiandrosterone sulfate [Mass/volume] in Serum or Plasma --2nd specimen post XXX challenge | Dehydroepiandrosterone sulfate^2nd specimen post XXX challenge |
| 16724-7 | Dehydroepiandrosterone sulfate [Mass/volume] in Serum or Plasma --3rd specimen post XXX challenge | Dehydroepiandrosterone sulfate^3rd specimen post XXX challenge |
| 16725-4 | Dehydroepiandrosterone sulfate [Mass/volume] in Serum or Plasma --4th specimen post XXX challenge | Dehydroepiandrosterone sulfate^4th specimen post XXX challenge |
| 16726-2 | Dehydroepiandrosterone sulfate [Mass/volume] in Serum or Plasma --5th specimen post XXX challenge | Dehydroepiandrosterone sulfate^5th specimen post XXX challenge |
| 16727-0 | Dehydroepiandrosterone sulfate [Mass/volume] in Serum or Plasma --6th specimen post XXX challenge | Dehydroepiandrosterone sulfate^6th specimen post XXX challenge |
| 16728-8 | Dehydroepiandrosterone sulfate [Mass/volume] in Serum or Plasma --7th specimen post XXX challenge | Dehydroepiandrosterone sulfate^7th specimen post XXX challenge |
| 16729-6 | Dehydroepiandrosterone sulfate [Mass/volume] in Serum or Plasma --8th specimen post XXX challenge | Dehydroepiandrosterone sulfate^8th specimen post XXX challenge |
| 16730-4 | Dehydroepiandrosterone sulfate [Mass/volume] in Serum or Plasma --9th specimen post XXX challenge | Dehydroepiandrosterone sulfate^9th specimen post XXX challenge |
| 49889-9 | Dehydroepiandrosterone sulfate [Mass/volume] in Serum or Plasma --pre dose corticotropin | Dehydroepiandrosterone sulfate^pre dose corticotropin |
| 16731-2 | None | Dehydroepiandrosterone.unconjugated |
| 2196-4 | Dehydroepiandrosterone.unconjugated [Mass/volume] in Serum or Plasma | Dehydroepiandrosterone.unconjugated |
| 2197-2 | Dehydroepiandrosterone.unconjugated [Mass/time] in 24 hour Urine | Dehydroepiandrosterone.unconjugated |
| 29879-4 | Dehydroepiandrosterone/Creatinine [Mass ratio] in 24 hour Urine | Dehydroepiandrosterone/Creatinine |
| 34283-2 | Dehydroepiandrosterone/Creatinine [Molecular ratio] in Urine | Dehydroepiandrosterone/Creatinine |
| 13862-8 | Dehydroepiandrosterone [Mass/volume] in Serum or Plasma --15 minutes post 250 ug corticotropin | Dehydroepiandrosterone^15M post 250 ug corticotropin |
| 13863-6 | Dehydroepiandrosterone [Mass/volume] in Serum or Plasma --1 hour post 250 ug corticotropin | Dehydroepiandrosterone^1H post 250 ug corticotropin |
| 49887-3 | Dehydroepiandrosterone [Mass/volume] in Serum or Plasma --1st specimen post XXX challenge | Dehydroepiandrosterone^1st specimen post XXX challenge |
| 12590-6 | Dehydroepiandrosterone [Mass/volume] in Serum or Plasma --2nd specimen post XXX challenge | Dehydroepiandrosterone^2nd specimen post XXX challenge |
| 13864-4 | Dehydroepiandrosterone [Mass/volume] in Serum or Plasma --30 minutes post 250 ug corticotropin | Dehydroepiandrosterone^30M post 250 ug corticotropin |
| 12591-4 | Dehydroepiandrosterone [Mass/volume] in Serum or Plasma --3rd specimen post XXX challenge | Dehydroepiandrosterone^3rd specimen post XXX challenge |
| 12592-2 | Dehydroepiandrosterone [Mass/volume] in Serum or Plasma --4th specimen post XXX challenge | Dehydroepiandrosterone^4th specimen post XXX challenge |
| 12593-0 | Dehydroepiandrosterone [Mass/volume] in Serum or Plasma --5th specimen post XXX challenge | Dehydroepiandrosterone^5th specimen post XXX challenge |
| 12594-8 | Dehydroepiandrosterone [Mass/volume] in Serum or Plasma --6th specimen post XXX challenge | Dehydroepiandrosterone^6th specimen post XXX challenge |
| 16732-0 | Dehydroepiandrosterone [Mass/volume] in Serum or Plasma --7th specimen post XXX challenge | Dehydroepiandrosterone^7th specimen post XXX challenge |
| 16733-8 | Dehydroepiandrosterone [Mass/volume] in Serum or Plasma --9th specimen post XXX challenge | Dehydroepiandrosterone^9th specimen post XXX challenge |
| 16734-6 | Dehydroepiandrosterone [Mass/volume] in Serum or Plasma --baseline | Dehydroepiandrosterone^baseline |
| 16735-3 | Dehydroepiandrosterone [Mass/volume] in Serum or Plasma --post XXX challenge | Dehydroepiandrosterone^post XXX challenge |
| 47852-9 | Dehydroepiandrosterone [Mass/volume] in Serum or Plasma --pre 250 ug corticotropin | Dehydroepiandrosterone^pre 250 ug corticotropin |
| 53211-9 | Dehydrosebacylcarnitine (C10:1-DC) [Molecules/volume] in Blood dot (filter paper) | Dehydrosebacylcarnitine (C10:1-DC) |
| 53209-3 | Dehydrosuberylcarnitine (C8:1-DC) [Molecules/volume] in Blood dot (filter paper) | Dehydrosuberylcarnitine (C8:1-DC) |
| 42634-6 | Del(1p,19q) gene deletion [Presence] in Fixed tissue by Molecular genetics method | Del(1p,19q) gene deletion |
| 42715-3 | del(5)(q12-35) deletion [Identifier] in Blood or Tissue by Molecular genetics method Nominal | Del(5)(q12-35) gene deletion |
| 27082-7 | Delavirdine [Mass/volume] in Serum or Plasma | Delavirdine |
| 29115-3 | Delavirdine [Units/volume] in Serum or Plasma | Delavirdine |
| 30276-0 | Delavirdine [Susceptibility] by Phenotype method | Delavirdine |
| 30290-1 | Delavirdine [Susceptibility] by Genotype method | Delavirdine |
| 30305-7 | Delavirdine [Susceptibility] | Delavirdine |
| 52586-5 | None | Delayed healing of surgical wound |
| 45896-8 | None | Delirium trigger |
| 11778-8 | None | Delivery date |
| 11779-6 | None | Delivery date |
| 11780-4 | None | Delivery date |
| 11781-2 | None | Delivery date |
| 53692-0 | None | Delivery date |
| 53694-6 | None | Delivery date |
| 42840-9 | None | Delivery risk |
| 18214-7 | Delta 5-Pregnanetriol [Mass/volume] in Urine | Delta 5-Pregnanetriol |
| 6699-3 | Delta 5-Pregnanetriol [Mass/time] in 24 hour Urine | Delta 5-Pregnanetriol |
| 18215-4 | Delta alanine [Mass/volume] in Urine | Delta alanine |
| 11215-1 | Delta aminolevulinate [Mass/volume] in Urine | Delta aminolevulinate |
| 12475-0 | Delta aminolevulinate [Mass/time] in Urine | Delta aminolevulinate |
| 14689-4 | Delta aminolevulinate [Molecules/time] in 24 hour Urine | Delta aminolevulinate |
| 2198-0 | Delta aminolevulinate [Mass/volume] in Plasma | Delta aminolevulinate |
| 2199-8 | Delta aminolevulinate [Mass/volume] in Serum | Delta aminolevulinate |
| 2200-4 | Delta aminolevulinate [Mass/time] in 24 hour Urine | Delta aminolevulinate |
| 25896-2 | Delta aminolevulinate [Molecules/volume] in 24 hour Urine | Delta aminolevulinate |
| 26974-6 | Delta aminolevulinate [Mass/volume] in 24 hour Urine | Delta aminolevulinate |
| 34284-0 | Delta aminolevulinate [Molecules/volume] in Urine | Delta aminolevulinate |
| 47088-0 | Delta aminolevulinate [Molecules/volume] in Serum | Delta aminolevulinate |
| 13728-1 | Delta aminolevulinate/Creatinine [Mass ratio] in Urine | Delta aminolevulinate/Creatinine |
| 25897-0 | Delta aminolevulinate/Creatinine [Molecular ratio] in 24 hour Urine | Delta aminolevulinate/Creatinine |
| 39782-8 | Delta aminolevulinate/Creatinine [Molecular ratio] in Urine | Delta aminolevulinate/Creatinine |
| 44313-5 | Delta aminolevulinate/Creatinine [Mass ratio] in 24 hour Urine | Delta aminolevulinate/Creatinine |
| 13970-9 | Delta tocopherol [Mass/volume] in Serum or Plasma | Delta tocopherol |
| 45698-8 | None | Delusions |
| 11170-8 | Dematiaceae IgE Ab [Units/volume] in Serum | Dematiaceae Ab.IgE |
| 10982-7 | Demeclocycline [Mass/volume] in Serum or Plasma | Demeclocycline |
| 18915-9 | Demeclocycline [Susceptibility] | Demeclocycline |
| 216-2 | Demeclocycline [Susceptibility] by Minimum lethal concentration (MLC) | Demeclocycline |
| 217-0 | Demeclocycline [Susceptibility] by Minimum inhibitory concentration (MIC) | Demeclocycline |
| 218-8 | Demeclocycline [Susceptibility] by Disk diffusion (KB) | Demeclocycline |
| 219-6 | Demeclocycline [Susceptibility] by Serum bactericidal titer | Demeclocycline |
| 29494-2 | Demeclocycline [Mass/volume] in Unspecified specimen | Demeclocycline |
| 7006-0 | Demeclocycline [Susceptibility] by Gradient strip (E-test) | Demeclocycline |
| 45656-6 | None | Dementia other than Alzheimer's disease |
| 45970-1 | None | Demographic information section |
| 47246-4 | None | Demographic information section |
| 46439-6 | None | Demographic section |
| 12377-8 | Demoxepam [Mass/volume] in Serum or Plasma | Demoxepam |
| 13556-6 | Demoxepam [Presence] in Serum or Plasma | Demoxepam |
| 16736-1 | Dengue virus 1 Ab [Titer] in Serum | Dengue virus 1 Ab |
| 22250-5 | Dengue virus 1 Ab [Presence] in Serum | Dengue virus 1 Ab |
| 31338-7 | Dengue virus 1 Ab [Units/volume] in Serum | Dengue virus 1 Ab |
| 7854-3 | Dengue virus 1 Ab [Presence] in Serum by Immunoassay | Dengue virus 1 Ab |
| 7855-0 | Dengue virus 1+2+3+4 RNA [Presence] in Serum by Probe & target amplification method | Dengue virus 1+2+3+4 RNA |
| 16737-9 | Dengue virus 2 Ab [Titer] in Serum | Dengue virus 2 Ab |
| 22251-3 | Dengue virus 2 Ab [Presence] in Serum | Dengue virus 2 Ab |
| 31339-5 | Dengue virus 2 Ab [Units/volume] in Serum | Dengue virus 2 Ab |
| 7856-8 | Dengue virus 2 Ab [Presence] in Serum by Immunoassay | Dengue virus 2 Ab |
| 16738-7 | Dengue virus 3 Ab [Titer] in Serum | Dengue virus 3 Ab |
| 22252-1 | Dengue virus 3 Ab [Presence] in Serum | Dengue virus 3 Ab |
| 31340-3 | Dengue virus 3 Ab [Units/volume] in Serum | Dengue virus 3 Ab |
| 7857-6 | Dengue virus 3 Ab [Presence] in Serum by Immunoassay | Dengue virus 3 Ab |
| 16739-5 | Dengue virus 4 Ab [Titer] in Serum | Dengue virus 4 Ab |
| 22253-9 | Dengue virus 4 Ab [Presence] in Serum | Dengue virus 4 Ab |
| 31341-1 | Dengue virus 4 Ab [Units/volume] in Serum | Dengue virus 4 Ab |
| 7858-4 | Dengue virus 4 Ab [Presence] in Serum by Immunoassay | Dengue virus 4 Ab |
| 16740-3 | Dengue virus Ab [Presence] in Serum | Dengue virus Ab |
| 31342-9 | Dengue virus Ab [Units/volume] in Unspecified specimen | Dengue virus Ab |
| 31343-7 | Dengue virus Ab [Presence] in Unspecified specimen | Dengue virus Ab |
| 33578-6 | Dengue virus Ab [Titer] in Serum by Immunofluorescence | Dengue virus Ab |
| 33606-5 | Dengue virus Ab [Titer] in Serum | Dengue virus Ab |
| 40515-9 | Dengue virus Ab [Titer] in Serum by Complement fixation | Dengue virus Ab |
| 40748-6 | Dengue virus Ab [Presence] in Serum by Hemaglutination inhibition | Dengue virus Ab |
| 50036-3 | Dengue virus Ab [Presence] in Unspecified specimen by Neutralization test | Dengue virus Ab |
| 6382-6 | None | Dengue virus Ab |
| 6383-4 | None | Dengue virus Ab |
| 7859-2 | Dengue virus Ab [Units/volume] in Serum | Dengue virus Ab |
| 23958-2 | Dengue virus IgG Ab [Units/volume] in Serum | Dengue virus Ab.IgG |
| 23991-3 | Dengue virus IgG Ab [Units/volume] in Serum by Immunoassay | Dengue virus Ab.IgG |
| 29661-6 | Dengue virus IgG Ab [Presence] in Serum by Immunoassay | Dengue virus Ab.IgG |
| 29676-4 | Dengue virus IgG Ab [Presence] in Serum | Dengue virus Ab.IgG |
| 6811-4 | Dengue virus IgG Ab [Titer] in Serum | Dengue virus Ab.IgG |
| 51785-4 | Dengue virus Ab.IgG & IgM [interpretation] in Serum | Dengue virus Ab.IgG & IgM |
| 41878-0 | Dengue virus IgG & IgM panel [Units/volume] in Serum by Immunoassay | Dengue virus Ab.IgG & IgM panel |
| 23968-1 | Dengue virus IgM Ab [Units/volume] in Serum | Dengue virus Ab.IgM |
| 23992-1 | Dengue virus IgM Ab [Units/volume] in Serum by Immunoassay | Dengue virus Ab.IgM |
| 25338-5 | Dengue virus IgM Ab [Presence] in Serum | Dengue virus Ab.IgM |
| 25392-2 | Dengue virus IgM Ab [Presence] in Serum by Immunoblot (IB) | Dengue virus Ab.IgM |
| 29663-2 | Dengue virus IgM Ab [Presence] in Serum by Immunoassay | Dengue virus Ab.IgM |
| 34721-1 | Dengue virus IgM Ab [Presence] in Cerebral spinal fluid | Dengue virus Ab.IgM |
| 6812-2 | Dengue virus IgM Ab [Titer] in Serum | Dengue virus Ab.IgM |
| 31798-2 | Dengue virus Ag [Presence] in Serum | Dengue virus Ag |
| 31799-0 | Dengue virus Ag [Presence] in Unspecified specimen | Dengue virus Ag |
| 6384-2 | Dengue virus Ag [Presence] in Serum by Immunofluorescence | Dengue virus Ag |
| 6385-9 | Dengue virus Ag [Presence] in Unspecified specimen by Immunofluorescence | Dengue virus Ag |
| 6386-7 | Dengue virus DNA [Presence] in Serum by DNA probe | Dengue virus DNA |
| 6387-5 | Dengue virus DNA [Presence] in Unspecified specimen by DNA probe | Dengue virus DNA |
| 28088-3 | None | Denial |
| 32883-1 | None | Dental arch |
| 45912-3 | None | Dental care trigger |
| 34043-0 | None | Dental examination method |
| 34047-1 | None | Dental history contribution |
| 34048-9 | None | Dental material used &or Proposed |
| 34016-6 | None | Dental plaque |
| 32881-5 | None | Dental probing response |
| 32964-9 | None | Dental prognosis |
| 32965-6 | None | Dental prognosis |
| 32966-4 | None | Dental prognosis |
| 34026-5 | None | Dental prosthesis |
| 39173-0 | None | Dental screen assessment |
| 39176-3 | None | Dental screen finding recency |
| 39175-5 | None | Dental screen follow-up status |
| 39174-8 | None | Dental screen results indicator |
| 32874-0 | None | Dental treatment anatomical site access |
| 52040-3 | Dental X-rays and Other Images (Not DICOM) | Dental X-rays and other images (not DICOM) attachment |
| 28266-5 | None | Dentition.behavior |
| 28459-6 | None | Dentition.behavior |
| 28267-3 | None | Dentition.knowledge |
| 28460-4 | None | Dentition.knowledge |
| 28268-1 | None | Dentition.status |
| 28461-2 | None | Dentition.status |
| 34031-5 | None | Denture base evaluation |
| 34033-1 | None | Denture occlusion |
| 34032-3 | None | Denture teeth evaluation |
| 2201-2 | Deoxycholate [Mass/volume] in Serum | Deoxycholate |
| 30520-1 | Deoxycholate [Molecules/volume] in Serum | Deoxycholate |
| 2202-0 | Deoxycholylglycine [Mass/volume] in Serum | Deoxycholylglycine |
| 39533-5 | Deoxyhemoglobin [Mass/volume] in Blood | Deoxyhemoglobin |
| 19225-2 | Deoxyhemoglobin/Hemoglobin.total in Arterial blood | Deoxyhemoglobin/Hemoglobin.total |
| 19226-0 | Deoxyhemoglobin/Hemoglobin.total in Capillary blood | Deoxyhemoglobin/Hemoglobin.total |
| 19227-8 | Deoxyhemoglobin/Hemoglobin.total in Venous blood | Deoxyhemoglobin/Hemoglobin.total |
| 19228-6 | Deoxyhemoglobin/Hemoglobin.total in Mixed venous blood | Deoxyhemoglobin/Hemoglobin.total |
| 4536-9 | Deoxyhemoglobin/Hemoglobin.total in Blood | Deoxyhemoglobin/Hemoglobin.total |
| 11216-9 | Deoxypyridinoline [Mass/volume] in Urine | Deoxypyridinoline |
| 15055-7 | Deoxypyridinoline [Molecules/time] in 24 hour Urine | Deoxypyridinoline |
| 15056-5 | None | Deoxypyridinoline |
| 25898-8 | Deoxypyridinoline [Molecules/volume] in 24 hour Urine | Deoxypyridinoline |
| 27424-1 | Deoxypyridinoline [Molecules/volume] in Urine | Deoxypyridinoline |
| 6936-9 | Deoxypyridinoline [Mass/time] in 2 hour Urine | Deoxypyridinoline |
| 6937-7 | Deoxypyridinoline [Mass/time] in 24 hour Urine | Deoxypyridinoline |
| 13881-8 | Deoxypyridinoline Free/Creatinine [Molecular ratio] in Urine | Deoxypyridinoline.free/Creatinine |
| 13729-9 | Deoxypyridinoline/Creatinine [Mass ratio] in Urine | Deoxypyridinoline/Creatinine |
| 13730-7 | Deoxypyridinoline/Creatinine [Mass ratio] in 24 hour Urine | Deoxypyridinoline/Creatinine |
| 13731-5 | Deoxypyridinoline/Creatinine [Mass ratio] in 2 hour Urine | Deoxypyridinoline/Creatinine |
| 24456-6 | Deoxypyridinoline/Creatinine [Molecular ratio] in 24 hour Urine | Deoxypyridinoline/Creatinine |
| 25095-1 | Deoxypyridinoline/Creatinine [Molecular ratio] in Urine | Deoxypyridinoline/Creatinine |
| 25096-9 | Deoxypyridinoline/Creatinine [Molecular ratio] in 2 hour Urine | Deoxypyridinoline/Creatinine |
| 35646-9 | Deoxypyridinoline/Creatinine [Molecular ratio] in unspecified time Urine | Deoxypyridinoline/Creatinine |
| 5129-2 | Deoxyribonuclease Ab [Units/volume] in Serum | Deoxyribonuclease Ab |
| 13091-4 | Deoxyribonucleoprotein Ab [Units/volume] in Serum | Deoxyribonucleoprotein Ab |
| 47957-6 | Deoxyuridine [Molecules/volume] in Serum or Plasma | Deoxyuridine |
| 34087-7 | None | Dependence section |
| 28378-8 | None | Depression |
| 45666-5 | None | Depression |
| 46472-7 | None | Depressive feelings |
| 39114-4 | None | Depth |
| 39127-6 | None | Depth |
| 9798-0 | Depth of Stone | Depth |
| 44661-7 | None | Depth of invasion by tumor |
| 44662-5 | None | Depth of invasion by tumor cannot be determined comment |
| 46671-4 | None | Depth perception |
| 21839-6 | None | Derivation method |
| 42103-2 | None | Derived American Joint Committee on cancer conversion method |
| 42098-4 | None | Derived American Joint Committee on Cancer M |
| 42099-2 | None | Derived American Joint Committee on Cancer M descriptor |
| 42096-8 | None | Derived American Joint Committee on Cancer N |
| 42097-6 | None | Derived American Joint Committee on Cancer N descriptor |
| 42100-8 | None | Derived American Joint Committee on Cancer stage group |
| 42094-3 | None | Derived American Joint Committee on Cancer T |
| 42095-0 | None | Derived American Joint Committee on Cancer T descriptor |
| 42101-6 | None | Derived SEER summary stage 1977 |
| 42104-0 | None | Derived SEER summary stage 1977 conversion method |
| 42102-4 | None | Derived SEER summary stage 2000 |
| 42105-7 | None | Derived SEER summary stage 2000 conversion method |
| 2203-8 | Dermatan sulfate [Mass/volume] in Serum or Plasma | Dermatan sulfate |
| 2204-6 | Dermatan sulfate [Mass/volume] in Urine | Dermatan sulfate |
| 47615-0 | Dermatan sulfate [Presence] in Urine | Dermatan sulfate |
| 44461-2 | American house dust mite Ab [Presence] in Serum by Immune diffusion (ID) | Dermatophagoides farinae Ab |
| 6095-4 | American house dust mite IgE Ab [Units/volume] in Serum | Dermatophagoides farinae Ab.IgE |
| 15680-2 | American house dust mite IgE Ab RAST class in Serum | Dermatophagoides farinae Ab.IgE.RAST class |
| 16741-1 | American house dust mite IgG Ab [Presence] in Blood | Dermatophagoides farinae Ab.IgG |
| 51534-6 | American house dust mite IgG Ab [Presence] in Serum | Dermatophagoides farinae Ab.IgG |
| 7276-9 | American house dust mite IgG Ab [Units/volume] in Serum | Dermatophagoides farinae Ab.IgG |
| 26419-2 | American house dust mite IgG4 Ab [Units/volume] in Serum | Dermatophagoides farinae Ab.IgG4 |
| 26420-0 | American house dust mite IgG4 Ab RAST class in Serum | Dermatophagoides farinae Ab.IgG4.RAST class |
| 7277-7 | American house dust mite triggered histamine release [Units/volume] in Blood | Dermatophagoides farinae basophil bound Ab |
| 48235-6 | American house dust mite triggered leukotriene release [Mass/volume] by Leukocytes | Dermatophagoides farinae leukotriene release |
| 14036-8 | Dermatophagoides microceras IgE Ab [Units/volume] in Serum | Dermatophagoides microceras Ab.IgE |
| 15681-0 | Dermatophagoides microceras IgE Ab RAST class in Serum | Dermatophagoides microceras Ab.IgE.RAST class |
| 6096-2 | European house dust mite IgE Ab [Units/volume] in Serum | Dermatophagoides pteronyssinus Ab.IgE |
| 15682-8 | European house dust mite IgE Ab RAST class in Serum | Dermatophagoides pteronyssinus Ab.IgE.RAST class |
| 16742-9 | European house dust mite IgG Ab [Presence] in Blood | Dermatophagoides pteronyssinus Ab.IgG |
| 51533-8 | European house dust mite IgG Ab [Presence] in Serum | Dermatophagoides pteronyssinus Ab.IgG |
| 7278-5 | European house dust mite IgG Ab [Units/volume] in Serum | Dermatophagoides pteronyssinus Ab.IgG |
| 26421-8 | European house dust mite IgG4 Ab [Units/volume] in Serum | Dermatophagoides pteronyssinus Ab.IgG4 |
| 26422-6 | European house dust mite IgG4 Ab RAST class in Serum | Dermatophagoides pteronyssinus Ab.IgG4.RAST class |
| 7279-3 | European house dust mite triggered histamine release [Units/volume] in Blood | Dermatophagoides pteronyssinus basophil bound Ab |
| 48236-4 | European house dust mite triggered leukotriene release [Mass/volume] by Leukocytes | Dermatophagoides pteronyssinus leukotriene release |
| 41271-8 | Dermatophagoides sp IgE Ab [Units/volume] in Serum | Dermatophagoides sp Ab.IgE |
| 43276-5 | Dermatophagoides sp IgE Ab RAST class in Serum | Dermatophagoides sp Ab.IgE.RAST class |
| 23025-0 | Dermatophilus congolensis [Presence] in Skin by Giemsa stain | Dermatophilus congolensis |
| 23595-2 | Dermatophilus congolensis [Presence] in Exudate by Giemsa stain | Dermatophilus congolensis |
| 23596-0 | Dermatophilus congolensis [Presence] in Exudate by Carbol-fuchsin stain | Dermatophilus congolensis |
| 23597-8 | Dermatophilus congolensis [Presence] in Exudate by Methylene blue stain | Dermatophilus congolensis |
| 23026-8 | Dermatophilus congolensis Ab [Presence] in Serum | Dermatophilus congolensis Ab |
| 23027-6 | Dermatophilus congolensis Ab [Presence] in Serum by Immunoassay | Dermatophilus congolensis Ab |
| 23028-4 | Dermatophilus congolensis Ag [Presence] in Tissue by Immunofluorescence | Dermatophilus congolensis Ag |
| 23598-6 | Dermatophilus congolensis Ag [Presence] in Exudate by Immunofluorescence | Dermatophilus congolensis Ag |
| 31800-6 | Dermatophilus congolensis Ag [Presence] in Exudate | Dermatophilus congolensis Ag |
| 21239-9 | Desalkylhalazepam [Mass/volume] in Serum or Plasma | Desalkylhalazepam |
| 51195-6 | Desbutylbupivacaine [Mass/volume] in Serum or Plasma | Desbutylbupivacaine |
| 52019-7 | Ambulance transport, description of services performed to support level of service | Description of services performed to support level of service |
| 34089-3 | None | Description section |
| 21909-7 | None | Descriptor.clinical |
| 21916-2 | None | Descriptor.other |
| 21903-0 | None | Descriptor.pathology |
| 25393-0 | Desethylamiodarone [Molecules/volume] in Serum or Plasma | Desethylamiodarone |
| 4211-9 | Desethylamiodarone [Mass] of Dose | Desethylamiodarone |
| 6774-4 | Desethylamiodarone [Mass/volume] in Serum or Plasma | Desethylamiodarone |
| 14691-0 | Desipramine [Molecules/volume] in Serum or Plasma | Desipramine |
| 14692-8 | Desipramine [Molecules/volume] in Urine | Desipramine |
| 29409-0 | Desipramine [Mass/volume] in Gastric fluid | Desipramine |
| 3531-1 | Desipramine [Mass/volume] in Serum or Plasma | Desipramine |
| 3532-9 | Desipramine [Presence] in Serum or Plasma | Desipramine |
| 3533-7 | Desipramine [Presence] in Urine | Desipramine |
| 3534-5 | Desipramine [Mass/volume] in Urine | Desipramine |
| 35606-3 | Desipramine [Mass/volume] in Serum or Plasma by Screen method | Desipramine |
| 40358-4 | Desipramine [Presence] in Gastric fluid | Desipramine |
| 4212-7 | Desipramine [Mass] of Dose | Desipramine |
| 3535-2 | Desipramine [Mass/volume] in Serum or Plasma --trough | Desipramine^trough |
| 9698-2 | None | Desmethylclomipramine |
| 12385-1 | None | Desmethyldoxepin |
| 16745-2 | None | Desmethylmethsuximide |
| 10476-0 | Desmin Ag [Presence] in Tissue by Immune stain | Desmin Ag |
| 43309-4 | Desmoglein 1 & Desmoglein 3 Ab panel [Units/volume] in Serum | Desmoglein 1 & Desmoglein 3 Ab panel |
| 43311-0 | Desmoglein 1 Ab [Units/volume] in Serum | Desmoglein 1 Ab |
| 43312-8 | Desmoglein 3 Ab [Units/volume] in Serum | Desmoglein 3 Ab |
| 11072-6 | Despropionylfentanyl [Mass/volume] in Serum or Plasma | Despropionylfentanyl |
| 11073-4 | Despropionylfentanyl [Mass/volume] in Urine | Despropionylfentanyl |
| 18582-7 | Ambulance transport destination site name | Destination site |
| 18583-5 | Ambulance transport, destination site address | Destination site |
| 15512-7 | Ambulance transport, destination site information (composite) | Destination site information |
| 52002-3 | Latitude coordinate | Destination site latitude |
| 52003-1 | Longitude coordinate | Destination site longitude |
| 52026-2 | Ambulance transport,destination site information - name and address | Destination site name & address |
| 51899-3 | None | Details |
| 14696-9 | Deuteroporphyrin [Molecules/volume] in Stool | Deuteroporphyrin |
| 23852-7 | Deuteroporphyrin [Mass/time] in unspecified time Stool | Deuteroporphyrin |
| 45307-6 | Deuteroporphyrin [Molecules/mass] in Stool | Deuteroporphyrin |
| 33619-8 | Deuteroporphyrin.semi-proto [Mass/time] in 24 hour Stool | Deuteroporphyrin.semi-proto |
| 44615-3 | None | Device error code |
| 46067-5 | None | Devices and restraints |
| 14062-4 | Dexamethasone [Mass/volume] in Serum or Plasma | Dexamethasone |
| 46948-6 | Dexamethasone [Mass/volume] in Urine | Dexamethasone |
| 15366-8 | Dextroamphetamine [Mass/volume] in Urine | Dextroamphetamine |
| 19419-1 | Dextroamphetamine [Presence] in Urine by Screen method | Dextroamphetamine |
| 19420-9 | Dextroamphetamine [Presence] in Urine by Confirm method | Dextroamphetamine |
| 20525-2 | Dextroamphetamine [Mass/volume] in Urine by Confirm method | Dextroamphetamine |
| 9814-5 | Dextroamphetamine [Mass/volume] in Serum or Plasma | Dextroamphetamine |
| 19421-7 | Dextroamphetamine cutoff [Mass/volume] in Urine for Screen method | Dextroamphetamine cutoff |
| 19422-5 | Dextroamphetamine cutoff [Mass/volume] in Urine for Confirm method | Dextroamphetamine cutoff |
| 31025-0 | Dextroamphetamine/Amphetamines.total in Urine | Dextroamphetamine/Amphetamines.total |
| 13497-3 | Dextroamphetamine/Levoamphetamine [Mass ratio] in Urine | Dextroamphetamine/Levoamphetamine |
| 32642-1 | Dextroamphetamine/Levoamphetamine [Mass ratio] in Serum or Plasma | Dextroamphetamine/Levoamphetamine |
| 12477-6 | Dextromethamphetamine [Mass/volume] in Urine | Dextromethamphetamine |
| 19423-3 | Dextromethamphetamine [Presence] in Urine by Screen method | Dextromethamphetamine |
| 19424-1 | Dextromethamphetamine [Presence] in Urine by Confirm method | Dextromethamphetamine |
| 19425-8 | Dextromethamphetamine [Mass/volume] in Urine by Confirm method | Dextromethamphetamine |
| 19426-6 | None | Dextromethamphetamine |
| 19427-4 | Dextromethamphetamine cutoff [Mass/volume] in Urine for Screen method | Dextromethamphetamine cutoff |
| 19428-2 | Dextromethamphetamine cutoff [Mass/volume] in Urine for Confirm method | Dextromethamphetamine cutoff |
| 31026-8 | Dextromethamphetamine/Amphetamines.total in Urine | Dextromethamphetamine/Amphetamines.total |
| 13498-1 | Dextromethamphetamine/Levomethamphetamine [Mass ratio] in Urine | Dextromethamphetamine/Levomethamphetamine |
| 32643-9 | Dextromethamphetamine/Levomethamphetamine [Mass ratio] in Serum or Plasma | Dextromethamphetamine/Levomethamphetamine |
| 13623-4 | Dextromethorphan [Mass/volume] in Serum or Plasma | Dextromethorphan |
| 16247-9 | Dextromethorphan [Mass/volume] in Serum or Plasma by Confirm method | Dextromethorphan |
| 21240-7 | Dextromethorphan [Mass/volume] in Urine | Dextromethorphan |
| 27413-4 | Dextromethorphan [Units/volume] in Serum or Plasma | Dextromethorphan |
| 3538-6 | Dextromethorphan [Presence] in Serum or Plasma | Dextromethorphan |
| 3539-4 | Dextromethorphan [Presence] in Urine | Dextromethorphan |
| 40359-2 | Dextromethorphan [Presence] in Unspecified specimen | Dextromethorphan |
| 4214-3 | Dextromethorphan [Mass] of Dose | Dextromethorphan |
| 52947-9 | Dextromethorphan [Presence] in Gastric fluid | Dextromethorphan |
| 27076-9 | Dextromethorphan+Levorphanol [Presence] in Urine | Dextromethorphan+Levorphanol |
| 16747-8 | Dextromoramide [Presence] in Serum or Plasma | Dextromoramide |
| 3540-2 | Dextromoramide [Presence] in Urine | Dextromoramide |
| 3541-0 | Dextromoramide [Mass/volume] in Urine | Dextromoramide |
| 4215-0 | Dextromoramide [Mass] of Dose | Dextromoramide |
| 14063-2 | Dezocine [Presence] in Urine | Dezocine |
| 16750-2 | Dezocine [Mass/volume] in Serum or Plasma | Dezocine |
| 16751-0 | Dezocine [Mass/volume] in Blood | Dezocine |
| 18216-2 | Dezocine [Presence] in Urine by Confirm method | Dezocine |
| 38297-8 | Di(2-Ethylhexyl) phthalate [Mass/volume] in Water | Di(2-Ethylhexyl) phthalate |
| 38636-7 | Di(2-Ethylhexyl) phthalate [Mass/volume] in Air | Di(2-Ethylhexyl) phthalate |
| 45636-8 | None | Diabetes mellitus |
| 33248-6 | Diabetes status [Identifier] | Diabetes status |
| 52588-1 | None | Diabetic foot ulcer(s) |
| 45672-3 | None | Diabetic retinopathy |
| 16752-8 | Diacetate [Presence] in Urine | Diacetate |
| 2205-3 | Diacetate [Mass/volume] in Serum | Diacetate |
| 19806-9 | None | Diagnosis |
| 19807-7 | None | Diagnosis |
| 19808-5 | None | Diagnosis |
| 19809-3 | None | Diagnosis |
| 19810-1 | None | Diagnosis |
| 19811-9 | None | Diagnosis |
| 29308-4 | None | Diagnosis |
| 29548-5 | None | Diagnosis |
| 46609-4 | None | Diagnosis and severity index |
| 52797-8 | None | Diagnosis ICD code |
| 39221-7 | None | Diagnosis recommendations |
| 39223-3 | None | Diagnosis recommendations, description |
| 39222-5 | None | Diagnosis recommendations, ICD9-CM |
| 18631-2 | Psychiatric rehabilitation treatment plan, diagnosis addressed by plan (composite) | Diagnosis.addressed by plan |
| 18821-9 | Psychiatric rehabilitation treatment plan, diagnosis addressed by plan (identifier) | Diagnosis.addressed by plan |
| 18822-7 | Psychiatric rehabilitation treatment plan, diagnosis addressed by plan (text) | Diagnosis.addressed by plan |
| 27465-4 | Cardiac rehabilitation treatment plan, diagnosis addressed by plan (identifier) | Diagnosis.addressed by plan |
| 27466-2 | Cardiac rehabilitation treatment plan, diagnosis addressed by plan (text) | Diagnosis.addressed by plan |
| 27477-9 | Alcohol-substance abuse rehabilitation treatment plan, diagnosis addressed by plan (composite) | Diagnosis.addressed by plan |
| 27518-0 | Cardiac rehabilitation treatment plan, diagnosis addressed by plan (composite) | Diagnosis.addressed by plan |
| 27528-9 | Alcohol-substance abuse rehabilitation treatment plan, diagnosis addressed by plan | Diagnosis.addressed by plan |
| 27529-7 | Alcohol-substance abuse rehabilitation treatment plan, diagnosis addressed by plan (text) | Diagnosis.addressed by plan |
| 27550-3 | Skilled nursing treatment plan, diagnosis addressed by plan (composite) | Diagnosis.addressed by plan |
| 27592-5 | Skilled nursing treatment plan, diagnosis addressed by plan (identifier) | Diagnosis.addressed by plan |
| 27593-3 | Skilled nursing treatment plan, diagnosis addressed by plan (text) | Diagnosis.addressed by plan |
| 27601-4 | Occupational therapy treatment plan, diagnosis addressed by plan (composite) | Diagnosis.addressed by plan |
| 27643-6 | Occupational therapy treatment plan, diagnosis addressed by plan (identifier) | Diagnosis.addressed by plan |
| 27644-4 | Occupational therapy treatment plan, diagnosis addressed by plan (text) | Diagnosis.addressed by plan |
| 27655-0 | Physical therapy treatment plan, diagnosis addressed by plan (identifier) | Diagnosis.addressed by plan |
| 27656-8 | Physical therapy treatment plan, diagnosis addressed by plan (text) | Diagnosis.addressed by plan |
| 27664-2 | Physical therapy treatment plan, diagnosis addressed by plan (composite) | Diagnosis.addressed by plan |
| 27703-8 | Respiratory therapy treatment plan, diagnosis addressed by plan (composite) | Diagnosis.addressed by plan |
| 27745-9 | Respiratory therapy treatment plan, diagnosis addressed by plan (identifier) | Diagnosis.addressed by plan |
| 27746-7 | Respiratory therapy treatment plan, diagnosis addressed by plan (text) | Diagnosis.addressed by plan |
| 27754-1 | Medical social services treatment plan, diagnosis addressed by plan (composite) | Diagnosis.addressed by plan |
| 27796-2 | Medical social services treatment plan, diagnosis addressed by plan (identifier) | Diagnosis.addressed by plan |
| 27797-0 | Medical social services treatment plan, diagnosis addressed by plan (text) | Diagnosis.addressed by plan |
| 29167-4 | Speech therapy treatment plan, diagnosis addressed by plan (composite) | Diagnosis.addressed by plan |
| 29192-2 | Speech therapy treatment plan, diagnosis addressed by plan (identifier) | Diagnosis.addressed by plan |
| 29193-0 | Speech therapy treatment plan, diagnosis addressed by plan (text) | Diagnosis.addressed by plan |
| 52142-7 | None | Diagnosis.addressed by plan |
| 52302-7 | None | Diagnosis.addressed by plan |
| 44833-2 | None | Diagnosis.preliminary |
| 18630-4 | Primary diagnosis | Diagnosis.primary |
| 18777-3 | Psychiatric rehabilitation treatment plan, primary diagnosis (text) | Diagnosis.primary |
| 18820-1 | Psychiatric rehabilitation treatment plan, primary diagnosis (identifier) | Diagnosis.primary |
| 19007-4 | Psychiatric rehabilitation treatment plan, primary diagnosis (composite) | Diagnosis.primary |
| 27457-1 | Cardiac rehabilitation treatment plan, primary diagnosis (composite) | Diagnosis.primary |
| 27460-5 | Cardiac rehabilitation treatment plan, primary diagnosis (text) | Diagnosis.primary |
| 27464-7 | Cardiac rehabilitation treatment plan, primary diagnosis (identifier) | Diagnosis.primary |
| 27515-6 | Alcohol-substance abuse rehabilitation treatment plan, primary diagnosis (composite) | Diagnosis.primary |
| 27523-0 | Alcohol-substance abuse rehabilitation treatment plan, primary diagnosis (text) | Diagnosis.primary |
| 27527-1 | Alcohol-substance abuse rehabilitation treatment plan, primary diagnosis | Diagnosis.primary |
| 27584-2 | Skilled nursing treatment plan, primary diagnosis (text) | Diagnosis.primary |
| 27587-5 | Skilled nursing treatment plan, primary diagnosis (composite) | Diagnosis.primary |
| 27591-7 | Skilled nursing treatment plan, primary diagnosis (identifier) | Diagnosis.primary |
| 27635-2 | Occupational therapy treatment plan, primary diagnosis (composite) | Diagnosis.primary |
| 27638-6 | Occupational therapy treatment plan, primary diagnosis (text) | Diagnosis.primary |
| 27642-8 | Occupational therapy treatment plan, primary diagnosis (identifier) | Diagnosis.primary |
| 27650-1 | Physical therapy treatment plan, primary diagnosis (text) | Diagnosis.primary |
| 27654-3 | Physical therapy treatment plan, primary diagnosis (identifier) | Diagnosis.primary |
| 27698-0 | Physical therapy treatment plan, primary diagnosis (composite) | Diagnosis.primary |
| 27737-6 | Respiratory therapy treatment plan, primary diagnosis (text) | Diagnosis.primary |
| 27740-0 | Respiratory therapy treatment plan, primary diagnosis (composite) | Diagnosis.primary |
| 27744-2 | Respiratory therapy treatment plan, primary diagnosis (identifier) | Diagnosis.primary |
| 27788-9 | Medical social services treatment plan, primary diagnosis (text) | Diagnosis.primary |
| 27791-3 | Medical social services treatment plan, primary diagnosis (composite) | Diagnosis.primary |
| 27795-4 | Medical social services treatment plan, primary diagnosis (identifier) | Diagnosis.primary |
| 29166-6 | Speech therapy treatment plan, primary diagnosis (composite) | Diagnosis.primary |
| 29194-8 | Speech therapy treatment plan, primary diagnosis (text) | Diagnosis.primary |
| 29195-5 | Speech thereapy treatment plan, primary diagnosis (identifier) | Diagnosis.primary |
| 46639-1 | None | Diagnosis.primary |
| 52137-7 | None | Diagnosis.primary |
| 52138-5 | None | Diagnosis.primary |
| 47048-4 | None | Diagnostic interventional study report |
| 27899-4 | Diagnostic studies non-lab (set) | Diagnostic studies.non lab |
| 16753-6 | None | Dialtrazene |
| 45842-2 | None | Dialysis |
| 42605-6 | Peritoneal dialysis bag number | Dialysis bag number |
| 29749-9 | Dialysis records | Dialysis records |
| 11782-0 | None | Diameter |
| 11783-8 | None | Diameter |
| 11784-6 | None | Diameter |
| 11785-3 | None | Diameter |
| 11786-1 | None | Diameter |
| 11787-9 | None | Diameter |
| 11788-7 | None | Diameter |
| 11789-5 | None | Diameter |
| 11790-3 | None | Diameter |
| 11791-1 | None | Diameter |
| 11792-9 | None | Diameter |
| 11793-7 | None | Diameter |
| 11794-5 | None | Diameter |
| 11795-2 | None | Diameter |
| 11796-0 | None | Diameter |
| 11797-8 | None | Diameter |
| 11798-6 | None | Diameter |
| 11799-4 | None | Diameter |
| 11800-0 | None | Diameter |
| 11801-8 | None | Diameter |
| 11802-6 | None | Diameter |
| 11803-4 | None | Diameter |
| 11804-2 | None | Diameter |
| 11805-9 | None | Diameter |
| 11806-7 | None | Diameter |
| 11807-5 | None | Diameter |
| 11808-3 | None | Diameter |
| 11809-1 | None | Diameter |
| 11810-9 | None | Diameter |
| 11811-7 | None | Diameter |
| 11812-5 | None | Diameter |
| 11813-3 | None | Diameter |
| 11814-1 | None | Diameter |
| 11815-8 | None | Diameter |
| 11816-6 | None | Diameter |
| 18006-7 | None | Diameter |
| 18007-5 | None | Diameter |
| 18010-9 | None | Diameter |
| 18011-7 | None | Diameter |
| 18012-5 | None | Diameter |
| 18013-3 | None | Diameter |
| 18014-1 | None | Diameter |
| 18015-8 | None | Diameter |
| 18016-6 | None | Diameter |
| 18017-4 | None | Diameter |
| 18018-2 | None | Diameter |
| 18019-0 | None | Diameter |
| 18020-8 | None | Diameter |
| 18021-6 | None | Diameter |
| 18022-4 | None | Diameter |
| 18023-2 | None | Diameter |
| 20166-5 | None | Diameter |
| 20272-1 | None | Diameter |
| 20307-5 | None | Diameter |
| 28882-9 | None | Diameter |
| 33171-0 | None | Diameter |
| 33441-7 | None | Diameter |
| 53658-1 | None | Diameter |
| 53669-8 | None | Diameter |
| 53671-4 | None | Diameter |
| 53672-2 | None | Diameter |
| 20273-9 | None | Diameter 2 |
| 33150-4 | None | Diameter product |
| 33191-8 | None | Diameter product |
| 11817-4 | None | Diameter product.largest pocket |
| 20348-9 | None | Diameter.4 chamber |
| 11818-2 | None | Diameter.anterior-posterior |
| 11819-0 | None | Diameter.anterior-posterior |
| 53656-5 | None | Diameter.anterior-posterior |
| 53683-9 | None | Diameter.anterior-posterior |
| 8294-1 | None | Diameter.anterior-posterior |
| 18024-0 | None | Diameter.anterior-posterior.systole |
| 29468-6 | None | Diameter.anterior-posterior.systole |
| 18025-7 | None | Diameter.anterior-posterior.systole/Diameter.aorta root |
| 8295-8 | None | Diameter.anterior-posterior^W expiration |
| 8296-6 | None | Diameter.anterior-posterior^W inspiration |
| 52728-3 | None | Diameter.any.max |
| 11820-8 | None | Diameter.biparietal |
| 33151-2 | None | Diameter.biparietal |
| 33153-8 | None | Diameter.biparietal |
| 33154-6 | None | Diameter.biparietal |
| 33155-3 | None | Diameter.biparietal |
| 33156-1 | None | Diameter.biparietal |
| 33198-3 | None | Diameter.biparietal |
| 33556-2 | None | Diameter.biparietal outer to inner |
| 33152-0 | None | Diameter.biparietal outer to outer |
| 11821-6 | None | Diameter.biparietal.mean |
| 11822-4 | None | Diameter.biparietal.mean |
| 11823-2 | None | Diameter.biparietal/Diameter.occipital |
| 33157-9 | None | Diameter.biparietal/Diameter.occipital |
| 33158-7 | None | Diameter.biparietal/Diameter.occipital |
| 11824-0 | None | Diameter.BPD.area-corrected |
| 53673-0 | None | Diameter.diastole |
| 53685-4 | None | Diameter.diastole |
| 11825-7 | None | Diameter.hilum-cortex |
| 11826-5 | None | Diameter.hilum-cortex |
| 11827-3 | None | Diameter.hilum-cortex |
| 11828-1 | None | Diameter.hilum-cortex |
| 11829-9 | None | Diameter.hilum-cortex |
| 11830-7 | None | Diameter.hilum-cortex |
| 11831-5 | None | Diameter.hilum-cortex.mean |
| 33070-4 | None | Diameter.inner orbital |
| 11832-3 | None | Diameter.largest pocket.max |
| 11833-1 | None | Diameter.largest pocket.mean |
| 38181-4 | None | Diameter.lateral |
| 11834-9 | None | Diameter.long |
| 11835-6 | None | Diameter.long |
| 11836-4 | None | Diameter.long |
| 11837-2 | None | Diameter.long |
| 11838-0 | None | Diameter.long |
| 11839-8 | None | Diameter.long |
| 11840-6 | None | Diameter.long |
| 11841-4 | None | Diameter.long |
| 11842-2 | None | Diameter.long |
| 11843-0 | None | Diameter.long.mean |
| 11844-8 | None | Diameter.long.mean |
| 11845-5 | None | Diameter.long.mean |
| 11846-3 | None | Diameter.max |
| 11847-1 | None | Diameter.max |
| 11848-9 | None | Diameter.max |
| 11849-7 | None | Diameter.mean |
| 11850-5 | None | Diameter.mean |
| 11851-3 | None | Diameter.occipito-frontal |
| 11852-1 | None | Diameter.outer to outer |
| 11853-9 | None | Diameter.perpendicular |
| 11854-7 | None | Diameter.perpendicular |
| 11855-4 | None | Diameter.perpendicular |
| 11856-2 | None | Diameter.perpendicular |
| 11857-0 | None | Diameter.perpendicular |
| 11858-8 | None | Diameter.perpendicular |
| 11859-6 | None | Diameter.perpendicular |
| 11860-4 | None | Diameter.sagittal |
| 11861-2 | None | Diameter.sagittal.mean |
| 20305-9 | None | Diameter.systole |
| 11862-0 | None | Diameter.transverse |
| 11863-8 | None | Diameter.transverse |
| 11864-6 | None | Diameter.transverse |
| 11865-3 | None | Diameter.transverse |
| 33181-9 | None | Diameter.transverse |
| 52729-1 | None | Diameter.transverse |
| 53655-7 | None | Diameter.transverse |
| 53682-1 | None | Diameter.transverse |
| 11866-1 | None | Diameter.transverse.mean |
| 42704-7 | None | Diameter^baseline |
| 29459-5 | None | Diameter^expiration |
| 29429-8 | None | Diameter^inspiration |
| 12326-5 | Diamorphine [Presence] in Unknown substance | Diamorphine |
| 16198-4 | Diamorphine [Presence] in Urine by Confirm method | Diamorphine |
| 16754-4 | Diamorphine [Mass/volume] in Unknown substance | Diamorphine |
| 16755-1 | Diamorphine [Mass/volume] in Urine by Confirm method | Diamorphine |
| 16756-9 | Diamorphine [Mass/volume] in Serum or Plasma by Confirm method | Diamorphine |
| 18387-1 | Diamorphine [Mass/volume] in Serum or Plasma | Diamorphine |
| 19439-9 | Diamorphine [Presence] in Urine by Screen method | Diamorphine |
| 3546-9 | Diamorphine [Presence] in Urine | Diamorphine |
| 3547-7 | Diamorphine [Mass/volume] in Urine | Diamorphine |
| 4216-8 | Diamorphine [Mass] of Dose | Diamorphine |
| 19441-5 | Diamorphine cutoff [Mass/volume] in Urine for Screen method | Diamorphine cutoff |
| 19442-3 | Diamorphine cutoff [Mass/volume] in Urine for Confirm method | Diamorphine cutoff |
| 28089-1 | None | Diarrhea |
| 28379-6 | None | Diarrhea |
| 45622-8 | None | Diarrhea |
| 18033-1 | None | Diastole-systole |
| 18026-5 | None | Diastole.max |
| 18027-3 | None | Diastole.max |
| 18028-1 | None | Diastole.max |
| 18029-9 | None | Diastole.max |
| 20234-1 | None | Diastole.max |
| 20235-8 | None | Diastole.max |
| 20236-6 | None | Diastole.max |
| 20237-4 | None | Diastole.max |
| 20238-2 | None | Diastole.max |
| 18032-3 | None | Diastole.pressure half time |
| 12378-6 | Diazepam [Presence] in Stool | Diazepam |
| 14697-7 | Diazepam [Molecules/volume] in Serum or Plasma | Diazepam |
| 16227-1 | Diazepam [Mass/volume] in Urine by Confirm method | Diazepam |
| 18388-9 | Diazepam [Presence] in Urine by Confirm method | Diazepam |
| 19443-1 | Diazepam [Presence] in Urine by Screen method | Diazepam |
| 26784-9 | Diazepam [Mass/volume] in Serum or Plasma by Confirm method | Diazepam |
| 26837-5 | Diazepam [Mass/mass] in Hair | Diazepam |
| 26935-7 | Diazepam [Mass/mass] in Meconium | Diazepam |
| 27192-4 | Diazepam [Mass/volume] in Vitreous fluid | Diazepam |
| 27275-7 | Diazepam [Mass/mass] in Stool | Diazepam |
| 29384-5 | Diazepam [Mass/volume] in Gastric fluid | Diazepam |
| 3548-5 | Diazepam [Mass/volume] in Serum or Plasma | Diazepam |
| 3549-3 | Diazepam [Presence] in Serum or Plasma | Diazepam |
| 3550-1 | Diazepam [Presence] in Urine | Diazepam |
| 3551-9 | Diazepam [Mass/volume] in Urine | Diazepam |
| 35607-1 | Diazepam [Mass/volume] in Serum or Plasma by Screen method | Diazepam |
| 4217-6 | Diazepam [Mass] of Dose | Diazepam |
| 48948-4 | Diazepam [Mass/volume] in Unspecified specimen | Diazepam |
| 52946-1 | Diazepam [Presence] in Gastric fluid | Diazepam |
| 49044-1 | Diazepam & Nordiazepam panel [Mass/volume] in Serum or Plasma | Diazepam & Nordiazepam panel |
| 19444-9 | Diazepam cutoff [Mass/volume] in Urine for Screen method | Diazepam cutoff |
| 19445-6 | Diazepam cutoff [Mass/volume] in Urine for Confirm method | Diazepam cutoff |
| 16757-7 | Diazepam+Nordiazepam [Mass/volume] in Serum or Plasma | Diazepam+Nordiazepam |
| 21241-5 | Diazepam+Nordiazepam [Mass/volume] in Urine | Diazepam+Nordiazepam |
| 50849-9 | Diazepam+Nordiazepam [Molecules/volume] in Serum or Plasma | Diazepam+Nordiazepam |
| 3552-7 | Diazepam [Mass/volume] in Serum or Plasma --trough | Diazepam^trough |
| 35479-5 | Diazinon [Mass/volume] in Urine | Diazinon |
| 35488-6 | Diazinon [Mass/volume] in Serum or Plasma | Diazinon |
| 5638-2 | Diazinon [Mass/volume] in Blood | Diazinon |
| 38657-3 | Diazomethane [Mass/volume] in Air | Diazomethane |
| 10534-6 | Diazoxide [Mass/volume] in Serum or Plasma | Diazoxide |
| 3553-5 | Dibenzepin [Mass/volume] in Blood | Dibenzepin |
| 4218-4 | Dibenzepin [Mass] of Dose | Dibenzepin |
| 38760-5 | Dibenzofuran [Mass/volume] in Air | Dibenzofuran |
| 4219-2 | None | Dibucaine nbr |
| 22754-6 | None | Dibucaine number |
| 3554-3 | None | Dibucaine number |
| 16758-5 | Dicamba [Mass/volume] in Serum or Plasma | Dicamba |
| 16759-3 | Dicamba [Mass/volume] in Urine | Dicamba |
| 53214-3 | Dicarboxydodecanoylcarnitine (C12-DC) [Molecules/volume] in Blood dot (filter paper) | Dicarboxydodecanoylcarnitine (C12-DC) |
| 53213-5 | Dicarboxydodecenoylcarnitine (C12:1-DC) [Molecules/volume] in Blood dot (filter paper) | Dicarboxydodecenoylcarnitine (C12:1-DC) |
| 2206-1 | Dicarboxylate, C6-C8-C10 [Mass/volume] in Serum | Dicarboxylate C6-C8-C10 |
| 2207-9 | Dicarboxylate, C6-C8-C10 [Mass/volume] in Urine | Dicarboxylate C6-C8-C10 |
| 16760-1 | Dicarboxylporphyrin [Mass/volume] in Blood | Dicarboxylporphyrin |
| 16761-9 | Dicarboxylporphyrin [Mass/volume] in Stool | Dicarboxylporphyrin |
| 21242-3 | Dicarboxylporphyrin [Mass/time] in unspecified time Stool | Dicarboxylporphyrin |
| 18466-3 | Dicarboxyoleoylcarnitine (C18:1-DC) [Mass/volume] in Serum or Plasma | Dicarboxyoleoylcarnitine (C18:1-DC) |
| 53219-2 | Dicarboxyoleylcarnitine (C18:1-DC) [Molecules/volume] in Blood dot (filter paper) | Dicarboxyoleylcarnitine (C18:1-DC) |
| 53217-6 | Dicarboxypalmitoleylcarnitine (C16:1-DC) [Molecules/volume] in Blood dot (filter paper) | Dicarboxypalmitoleylcarnitine (C16:1-DC) |
| 53218-4 | Dicarboxypalmitoylcarnitine (C16-DC) [Molecules/volume] in Blood dot (filter paper) | Dicarboxypalmitoylcarnitine (C16-DC) |
| 53220-0 | Dicarboxystearoylcarnitine (C18-DC) [Molecules/volume] in Blood dot (filter paper) | Dicarboxystearoylcarnitine (C18-DC) |
| 53216-8 | Dicarboxytetradecanoylcarnitine (C14:1-DC) [Molecules/volume] in Blood dot (filter paper) | Dicarboxytetradecanoylcarnitine (C14:1-DC) |
| 53215-0 | Dicarboxytetradecenoylcarnitine (C14-DC) [Molecules/volume] in Blood dot (filter paper) | Dicarboxytetradecenoylcarnitine (C14-DC) |
| 16762-7 | Dichlorobenzene [Mass/volume] in Blood | Dichlorobenzene |
| 38315-8 | Dichlorobenzene [Mass/volume] in Water | Dichlorobenzene |
| 10911-6 | Dichlorobenzidine [Mass/volume] in Urine | Dichlorobenzidine |
| 38663-1 | Dichlorobenzidine [Mass/volume] in Air | Dichlorobenzidine |
| 12996-5 | Dichlorodifluoroethane [Mass/volume] in Blood | Dichlorodifluoroethane |
| 13935-2 | Dichlorodifluoromethane [Mass/volume] in Blood | Dichlorodifluoromethane |
| 11093-2 | Dichlorodiphenyldichloroethylene [Mass/volume] in Serum or Plasma | Dichlorodiphenyldichloroethylene |
| 14262-0 | Dichlorodiphenyldichloroethylene [Mass/mass] in Tissue | Dichlorodiphenyldichloroethylene |
| 16763-5 | Dichlorodiphenyldichloroethylene [Mass/volume] in Urine | Dichlorodiphenyldichloroethylene |
| 16764-3 | Dichlorodiphenyldichloroethylene [Mass/volume] in Blood | Dichlorodiphenyldichloroethylene |
| 38669-8 | Dichlorodiphenyldichloroethylene [Mass/volume] in Air | Dichlorodiphenyldichloroethylene |
| 11094-0 | Dichlorodiphenyltrichloroethane [Mass/volume] in Serum or Plasma | Dichlorodiphenyltrichloroethane |
| 14263-8 | Dichlorodiphenyltrichloroethane [Mass/mass] in Tissue | Dichlorodiphenyltrichloroethane |
| 16765-0 | Dichlorodiphenyltrichloroethane [Mass/volume] in Milk | Dichlorodiphenyltrichloroethane |
| 26953-0 | Dichlorodiphenyltrichloroethane [Presence] in Serum or Plasma | Dichlorodiphenyltrichloroethane |
| 38340-6 | None | Dichlorodiphenyltrichloroethane |
| 53643-3 | Dichlorodiphenyltrichloroethane [Presence] in Gastric fluid | Dichlorodiphenyltrichloroethane |
| 12307-5 | Dichloroethane [Mass/volume] in Blood | Dichloroethane |
| 16766-8 | Dichloroethane [Presence] in Blood | Dichloroethane |
| 38316-6 | Dichloroethane [Mass/volume] in Water | Dichloroethane |
| 3555-0 | Dichlorphenamide [Presence] in Urine | Dichlorphenamide |
| 3556-8 | Dichlorphenamide [Mass/volume] in Urine | Dichlorphenamide |
| 3557-6 | Dichlorphenamide [Mass/time] in 24 hour Urine | Dichlorphenamide |
| 4220-0 | Dichlorphenamide [Mass] of Dose | Dichlorphenamide |
| 16768-4 | Dichlorvos [Mass/volume] in Urine | Dichlorvos |
| 30026-9 | Dichlorvos [Mass/volume] in Serum or Plasma | Dichlorvos |
| 38591-4 | Dichlorvos [Mass/volume] in Air | Dichlorvos |
| 9515-8 | Diclofenac [Mass/volume] in Serum or Plasma | Diclofenac |
| 48274-5 | Diclofenac triggered leukotriene release [Mass/volume] by Leukocytes | Diclofenac leukotriene release |
| 10984-3 | Dicloxacillin [Mass/volume] in Serum or Plasma | Dicloxacillin |
| 16769-2 | Dicloxacillin [Mass/volume] in Urine | Dicloxacillin |
| 18916-7 | Dicloxacillin [Susceptibility] | Dicloxacillin |
| 220-4 | Dicloxacillin [Susceptibility] by Minimum lethal concentration (MLC) | Dicloxacillin |
| 221-2 | Dicloxacillin [Susceptibility] by Minimum inhibitory concentration (MIC) | Dicloxacillin |
| 222-0 | Dicloxacillin [Susceptibility] by Disk diffusion (KB) | Dicloxacillin |
| 223-8 | Dicloxacillin [Susceptibility] by Serum bactericidal titer | Dicloxacillin |
| 25252-8 | Dicloxacillin [Mass/volume] in Unspecified specimen | Dicloxacillin |
| 32380-8 | None | Dicloxacillin |
| 16770-0 | Dicoumarol [Mass/volume] in Urine | Dicoumarol |
| 3558-4 | Dicoumarol [Mass/volume] in Serum or Plasma | Dicoumarol |
| 11489-2 | Provider, dictating practitioner - identifier | Dictating practitioner ID |
| 18770-8 | Provider, dictating practitioner - name | Dictating practitioner name |
| 16771-8 | Dicyclomine [Mass/volume] in Serum or Plasma | Dicyclomine |
| 45630-1 | None | Did not use toilet room &or commode &or urinal |
| 29116-1 | Didanosine [Units/volume] in Serum or Plasma | Didanosine |
| 30270-3 | Didanosine [Susceptibility] by Phenotype method | Didanosine |
| 30284-4 | Didanosine [Susceptibility] by Genotype method | Didanosine |
| 30300-8 | Didanosine [Susceptibility] | Didanosine |
| 48307-3 | Didanosine [Mass/volume] in Serum or Plasma | Didanosine |
| 26042-2 | Didesmethylcitalopram [Molecules/volume] in Serum or Plasma | Didesmethylcitalopram |
| 11095-7 | Dieldrin [Mass/volume] in Serum or Plasma | Dieldrin |
| 16772-6 | Dieldrin [Mass/volume] in Urine | Dieldrin |
| 16773-4 | Dieldrin [Mass/volume] in Blood | Dieldrin |
| 45746-5 | None | Dietary supplement between meals |
| 38665-6 | Diethanolamine [Mass/volume] in Air | Diethanolamine |
| 13936-0 | Diethyl ether [Mass/volume] in Blood | Diethyl ether |
| 21243-1 | Diethyl ether [Mass/volume] in Urine | Diethyl ether |
| 2208-7 | Diethyl ether [Mass/volume] in Serum or Plasma | Diethyl ether |
| 27001-7 | Diethyl ether [Presence] in Blood | Diethyl ether |
| 16774-2 | Diethylcarbamazepine [Mass/volume] in Serum or Plasma | Diethylcarbamazepine |
| 41474-8 | Diethylcarbamazepine [Mass/volume] in Blood dot (filter paper) | Diethylcarbamazepine |
| 34436-6 | Diethylene glycol [Mass/volume] in Serum or Plasma | Diethylene glycol |
| 16210-7 | Diethylpropion [Presence] in Urine by Confirm method | Diethylpropion |
| 16366-7 | Diethylpropion [Mass/volume] in Serum or Plasma | Diethylpropion |
| 21244-9 | None | Diethylpropion |
| 3345-6 | Diethylpropion [Presence] in Urine | Diethylpropion |
| 3346-4 | Diethylpropion [Mass/volume] in Urine | Diethylpropion |
| 3347-2 | Diethylpropion [Mass/time] in 24 hour Urine | Diethylpropion |
| 4124-4 | Diethylpropion [Mass] of Dose | Diethylpropion |
| 14064-0 | Diethylstilbestrol [Mass/volume] in Serum or Plasma | Diethylstilbestrol |
| 38666-4 | Diethylsulfate [Mass/volume] in Air | Diethylsulfate |
| 45615-2 | None | Difference in ADL Self-Performance or ADL Support, comparing mornings to evenings |
| 49024-3 | Differential cell count method [Type] in Blood | Differential cell count method |
| 24318-8 | Differential panel in Blood | Differential panel |
| 29580-8 | Differential panel in Body fluid | Differential panel |
| 29581-6 | Differential panel in Peritoneal fluid | Differential panel |
| 29582-4 | Differential panel in Synovial fluid | Differential panel |
| 29583-2 | Differential panel in Pleural fluid | Differential panel |
| 29584-0 | Differential panel in Cerebral spinal fluid | Differential panel |
| 47286-0 | Differential panel in Bone marrow | Differential panel |
| 28380-4 | None | Difficulty concentrating |
| 19910-9 | None | Diffusion capacity.carbon monoxide |
| 19911-7 | None | Diffusion capacity.carbon monoxide |
| 19912-5 | None | Diffusion capacity.carbon monoxide^^adjusted for hemoglobin |
| 19913-3 | None | Diffusion capacity.carbon monoxide^^adjusted for hemoglobin |
| 19914-1 | None | Diffusion capacity/Alveolar volume |
| 19915-8 | None | Diffusion capacity/Alveolar volume |
| 19916-6 | None | Diffusion capacity/Alveolar volume |
| 19917-4 | None | Diffusion capacity^^adjusted to body conditions |
| 19918-2 | None | Diffusion capacity^^adjusted to body conditions |
| 35790-5 | Difloxacin [Susceptibility] by Disk diffusion (KB) | Difloxacin |
| 35791-3 | Difloxacin [Susceptibility] by Minimum inhibitory concentration (MIC) | Difloxacin |
| 35792-1 | Difloxacin [Susceptibility] | Difloxacin |
| 14065-7 | Diflunisal [Mass/volume] in Serum or Plasma | Diflunisal |
| 28269-9 | None | Digestion-hydration.behavior |
| 28483-6 | None | Digestion-hydration.behavior |
| 46807-4 | None | Digestion-hydration.behavior |
| 28270-7 | None | Digestion-hydration.knowledge |
| 28484-4 | None | Digestion-hydration.knowledge |
| 46808-2 | None | Digestion-hydration.knowledge |
| 28271-5 | None | Digestion-hydration.status |
| 28485-1 | None | Digestion-hydration.status |
| 46809-0 | None | Digestion-hydration.status |
| 15104-3 | Digitoxin [Molecules/volume] in Serum or Plasma | Digitoxin |
| 29215-1 | Digitoxin [Mass/volume] in Body fluid | Digitoxin |
| 3559-2 | Digitoxin [Mass/volume] in Serum or Plasma | Digitoxin |
| 3560-0 | Digitoxin [Mass/volume] in Urine | Digitoxin |
| 4221-8 | Digitoxin [Mass] of Dose | Digitoxin |
| 3561-8 | Digitoxin>6h post dose [Mass/volume] in Serum or Plasma | Digitoxin>6h post dose |
| 10535-3 | Digoxin [Mass/volume] in Serum or Plasma | Digoxin |
| 14698-5 | Digoxin [Molecules/volume] in Serum or Plasma | Digoxin |
| 29216-9 | Digoxin [Mass/volume] in Body fluid | Digoxin |
| 35244-3 | Digoxin [Mass or Molecules/volume] in Serum or Plasma | Digoxin |
| 4222-6 | Digoxin [Mass] of Dose | Digoxin |
| 32067-1 | Digoxin Free [Molecules/volume] in Serum or Plasma | Digoxin.free |
| 3562-6 | Digoxin Free [Mass/volume] in Serum or Plasma | Digoxin.free |
| 3563-4 | Digoxin>12h post dose [Mass/volume] in Serum or Plasma | Digoxin>12h post dose |
| 48370-1 | Dihomogammalinolenate (C20:3n-6) [Molecules/volume] in Serum or Plasma | Dihomogammalinolenate |
| 14066-5 | Dihydrocodeine [Presence] in Urine | Dihydrocodeine |
| 14067-3 | Dihydrocodeine [Mass/volume] in Blood | Dihydrocodeine |
| 16211-5 | Dihydrocodeine [Presence] in Urine by Confirm method | Dihydrocodeine |
| 19446-4 | Dihydrocodeine [Presence] in Urine by Screen method | Dihydrocodeine |
| 19448-0 | Dihydrocodeine [Mass/volume] in Urine by Confirm method | Dihydrocodeine |
| 19449-8 | Dihydrocodeine [Mass/volume] in Urine | Dihydrocodeine |
| 42901-9 | Dihydrocodeine [Mass/volume] in Serum or Plasma | Dihydrocodeine |
| 19450-6 | Dihydrocodeine cutoff [Mass/volume] in Urine for Screen method | Dihydrocodeine cutoff |
| 19451-4 | Dihydrocodeine cutoff [Mass/volume] in Urine for Confirm method | Dihydrocodeine cutoff |
| 27035-5 | Dihydrocodeine+Hydrocodeinone [Mass/mass] in Meconium | Dihydrocodeine+Hydrocodeinone |
| 28072-7 | Dihydrocodeine+Hydrocodeinone [Mass/mass] in Stool | Dihydrocodeine+Hydrocodeinone |
| 46257-2 | Dihydrocodeine+Hydrocodol [Presence] in Serum or Plasma by Screen method | Dihydrocodeine+Hydrocodol |
| 51448-9 | Dihydrocodeine+Hydrocodol [Mass/volume] in Urine | Dihydrocodeine+Hydrocodol |
| 51765-6 | Dihydrocodeine+Hydrocodol [Mass/volume] in Serum or Plasma | Dihydrocodeine+Hydrocodol |
| 12785-2 | Dihydrocodeine Free [Mass/volume] in Serum or Plasma | Dihydrocodeine.free |
| 16775-9 | Dihydrocodeine Free [Presence] in Serum or Plasma by Confirm method | Dihydrocodeine.free |
| 46703-5 | Dihydrocodeine Free+Hydrocodol Free [Presence] in Serum or Plasma by Screen method | Dihydrocodeine.free+Hydrocodol.free |
| 46704-3 | Dihydrocodeine Free+Hydrocodol Free [Mass/volume] in Serum or Plasma by Screen method | Dihydrocodeine.free+Hydrocodol.free |
| 49750-3 | Dihydrocodeine Free+Hydrocodol Free [Mass/volume] in Serum or Plasma | Dihydrocodeine.free+Hydrocodol.free |
| 51955-3 | Dihydrocodeine Free+Hydrocodol Free [Mass/volume] in Urine | Dihydrocodeine.free+Hydrocodol.free |
| 2209-5 | Dihydrofolate [Mass/volume] in Serum | Dihydrofolate |
| 2210-3 | Dihydrolipoamide acetyl transferase [Enzymatic activity/mass] in Tissue | Dihydrolipoamide acetyl transferase |
| 2211-1 | Dihydrolipoamide dehydrogenase [Enzymatic activity/mass] in Tissue | Dihydrolipoamide dehydrogenase |
| 2212-9 | Dihydropteridine reductase [Enzymatic activity/volume] in Serum | Dihydropteridine reductase |
| 24081-2 | Dihydroxyacetone phosphate acylcoa acyl transferase [Enzymatic activity/mass] in Fibroblast | Dihydroxyacetone phosphate acylcoa acyl transferase |
| 53479-2 | Dihydroxycholestanoate [Molecules/volume] in Serum or Plasma | Dihydroxycholestanoate |
| 13015-3 | Diisobutylketone [Mass/volume] in Blood | Diisobutylketone |
| 21245-6 | Diisobutylketone [Mass/volume] in Urine | Diisobutylketone |
| 16776-7 | Diltiazem [Mass/volume] in Urine | Diltiazem |
| 6898-1 | Diltiazem [Mass/volume] in Serum or Plasma | Diltiazem |
| 53977-5 | Dimagnesium phosphate crystals [Presence] in Urine sediment by Light microscopy | Dimagnesium phosphate crystals |
| 12365-3 | Dimenhydrinate [Presence] in Urine | Dimenhydrinate |
| 12391-9 | Dimenhydrinate [Mass/volume] in Serum or Plasma | Dimenhydrinate |
| 39475-9 | Dimenhydrinate [Molecules/volume] in Serum or Plasma | Dimenhydrinate |
| 19452-2 | Dimetamphetamine [Presence] in Urine by Screen method | Dimetamphetamine |
| 19453-0 | Dimetamphetamine [Presence] in Urine by Confirm method | Dimetamphetamine |
| 20526-0 | Dimetamphetamine [Mass/volume] in Urine by Confirm method | Dimetamphetamine |
| 3564-2 | Dimetamphetamine [Presence] in Urine | Dimetamphetamine |
| 3565-9 | Dimetamphetamine [Mass/volume] in Urine | Dimetamphetamine |
| 3566-7 | Dimetamphetamine [Mass/time] in 24 hour Urine | Dimetamphetamine |
| 19454-8 | Dimetamphetamine cutoff [Mass/volume] in Urine for Screen method | Dimetamphetamine cutoff |
| 19455-5 | Dimetamphetamine cutoff [Mass/volume] in Urine for Confirm method | Dimetamphetamine cutoff |
| 2213-7 | Dimethadione [Mass/volume] in Serum or Plasma | Dimethadione |
| 21246-4 | Dimethoate [Mass/volume] in Urine | Dimethoate |
| 30027-7 | Dimethoate [Mass/volume] in Serum or Plasma | Dimethoate |
| 38689-6 | Dimethyl sulfate [Mass/volume] in Air | Dimethyl sulfate |
| 12372-9 | Dimethylacetamide [Mass/volume] in Urine | Dimethylacetamide |
| 16777-5 | Dimethylacetamide [Presence] in Urine | Dimethylacetamide |
| 38668-0 | Dimethylaniline [Mass/volume] in Air | Dimethylaniline |
| 13940-2 | Dimethylbenzene [Mass/volume] in Blood | Dimethylbenzene |
| 17772-5 | Dimethylbenzene [Mass/volume] in Urine | Dimethylbenzene |
| 29296-1 | Dimethylbenzene [Presence] in Blood | Dimethylbenzene |
| 38755-5 | Dimethylbenzene [Mass/volume] in Air | Dimethylbenzene |
| 5758-8 | None | Dimethylbenzene |
| 5759-6 | Dimethylbenzene [Mass/volume] in Serum or Plasma | Dimethylbenzene |
| 13832-1 | Dimethylbenzene/Creatinine [Mass ratio] in Urine | Dimethylbenzene/Creatinine |
| 38740-7 | Dimethylcarbamoyl chloride [Mass/volume] in Air | Dimethylcarbamoyl chloride |
| 38592-2 | Dimethylformamide [Mass/volume] in Air | Dimethylformamide |
| 23853-5 | Dimethylformamide/Creatinine [Mass ratio] in Urine | Dimethylformamide/Creatinine |
| 49837-8 | Dimethylphosphatidyl ethanolamine/Surfactant.total in Amniotic Fluid | Dimethylphosphatidyl ethanolamine/Surfactant.total |
| 38673-0 | Dimethylphthalate [Mass/volume] in Air | Dimethylphthalate |
| 12337-2 | Dimethylsulfoxide [Presence] in Serum or Plasma | Dimethylsulfoxide |
| 14098-8 | Dimethylsulfoxide [Mass/volume] in Serum or Plasma | Dimethylsulfoxide |
| 12292-9 | Dimethyltryptamine [Presence] in Urine | Dimethyltryptamine |
| 3567-5 | Dimethyltryptamine [Mass/volume] in Serum or Plasma | Dimethyltryptamine |
| 3568-3 | Dimethyltryptamine [Mass/volume] in Urine | Dimethyltryptamine |
| 2214-5 | Dinitrobenzene [Mass/volume] in Urine | Dinitrobenzene |
| 16778-3 | Dinitrophenol [Presence] in Serum or Plasma | Dinitrophenol |
| 16779-1 | Dinitrophenol [Mass/volume] in Urine | Dinitrophenol |
| 10661-7 | Dinoflagelate identified in Water by Light microscopy | Dinoflagelate identified |
| 38298-6 | Dinoseb [Mass/volume] in Water | Dinoseb |
| 7782-6 | Yam IgE Ab [Units/volume] in Serum | Dioscorea batatas Ab.IgE |
| 10947-0 | Persimmon IgE Ab [Units/volume] in Serum | Diospyros kaki Ab.IgE |
| 29862-0 | Persimmon IgE Ab RAST class in Serum | Diospyros kaki Ab.IgE.RAST class |
| 23854-3 | Dioxin [Mass/volume] in Serum or Plasma | Dioxin |
| 27316-9 | Dioxin [Presence] in Serum or Plasma | Dioxin |
| 38299-4 | Dioxin [Mass/volume] in Water | Dioxin |
| 38619-3 | Dioxin [Mass/volume] in Air | Dioxin |
| 2215-2 | Dipalmitoylphosphatidylcholine [Mass/volume] in Serum | Dipalmitoylphosphatidylcholine |
| 29531-1 | Diphenhydramine [Presence] in Unspecified specimen | Diphenhydramine |
| 35608-9 | Diphenhydramine [Mass/volume] in Serum or Plasma by Screen method | Diphenhydramine |
| 3569-1 | Diphenhydramine [Presence] in Serum or Plasma | Diphenhydramine |
| 3570-9 | Diphenhydramine [Mass/volume] in Serum or Plasma | Diphenhydramine |
| 3571-7 | Diphenhydramine [Presence] in Urine | Diphenhydramine |
| 3572-5 | Diphenhydramine [Mass/volume] in Urine | Diphenhydramine |
| 39476-7 | Diphenhydramine [Molecules/volume] in Serum or Plasma | Diphenhydramine |
| 4224-2 | Diphenhydramine [Mass] of Dose | Diphenhydramine |
| 14699-3 | Diphenhydramine+Dimenhydrinate [Presence] in Gastric fluid | Diphenhydramine+Dimenhydrinate |
| 14700-9 | Diphenhydramine+Dimenhydrinate [Presence] in Serum or Plasma | Diphenhydramine+Dimenhydrinate |
| 14701-7 | Diphenhydramine+Dimenhydrinate [Presence] in Urine | Diphenhydramine+Dimenhydrinate |
| 32068-9 | Diphenhydramine+Dimenhydrinate [Presence] in Unspecified specimen | Diphenhydramine+Dimenhydrinate |
| 12398-4 | Diphenoxylate [Mass/volume] in Serum or Plasma | Diphenoxylate |
| 4226-7 | None | Diphenylhydramine |
| 33335-1 | Diphenylmethoxyacetate [Presence] in Urine by Screen method | Diphenylmethoxyacetate |
| 11044-5 | Diphosphoglycerate mutase [Enzymatic activity/volume] in Red Blood Cells | Diphosphoglycerate mutase |
| 47853-7 | Diphosphoglycerate phosphatase [Enzymatic activity/mass] in Red Blood Cells | Diphosphoglycerate phosphatase |
| 14479-0 | Diphtheria identified in Throat by Organism specific culture | Diphtheria sp identified |
| 14480-8 | Diphtheria identified in Sputum by Organism specific culture | Diphtheria sp identified |
| 14481-6 | Diphtheria identified in Nose by Organism specific culture | Diphtheria sp identified |
| 14482-4 | Diphtheria identified in Skin by Organism specific culture | Diphtheria sp identified |
| 14483-2 | Diphtheria identified in Bronchial specimen by Organism specific culture | Diphtheria sp identified |
| 567-8 | Diphtheria identified in Unspecified specimen by Organism specific culture | Diphtheria sp identified |
| 6596-1 | Diphtheria identified in Isolate by Organism specific culture | Diphtheria sp identified |
| 3573-3 | Dipipanone [Presence] in Urine | Dipipanone |
| 3574-1 | Dipipanone [Mass/volume] in Urine | Dipipanone |
| 3575-8 | Dipipanone [Mass/time] in 24 hour Urine | Dipipanone |
| 4227-5 | Dipipanone [Mass] of Dose | Dipipanone |
| 10536-1 | Dipyridamole [Mass/volume] in Serum or Plasma | Dipyridamole |
| 9748-5 | Dipyridamole [Mass/volume] in Unspecified specimen | Dipyridamole |
| 48783-5 | Dipyrone IgE Ab [Units/volume] in Serum | Dipyrone Ab.IgE |
| 48782-7 | Dipyrone IgE Ab RAST class in Serum | Dipyrone Ab.IgE.RAST class |
| 48280-2 | Dipyrone triggered leukotriene release [Mass/volume] by Leukocytes | Dipyrone leukotriene release |
| 12339-8 | Diquat [Presence] in Urine | Diquat |
| 38300-0 | Diquat [Mass/volume] in Water | Diquat |
| 35521-4 | None | Direct access to source data+documents section |
| 1004-1 | Direct antiglobulin test.complement specific reagent [Presence] on Red Blood Cells | Direct antiglobulin test.complement specific reagent |
| 53744-9 | Direct antiglobulin test.complement specific reagent [Presence] on Red Blood Cells by 5 minute RT incubation | Direct antiglobulin test.complement specific reagent |
| 1006-6 | Direct antiglobulin test.IgG specific reagent [interpretation] on Red Blood Cells | Direct antiglobulin test.IgG specific reagent |
| 52114-6 | Direct antiglobulin test.IgG specific reagent [presence] on Cord red blood cells | Direct antiglobulin test.IgG specific reagent |
| 1007-4 | Direct antiglobulin test.poly specific reagent [Presence] on Red Blood Cells | Direct antiglobulin test.poly specific reagent |
| 1009-0 | None | Direct antiglobulin test.poly specific reagent |
| 51871-2 | Direct antiglobulin test.poly specific reagent [presence] on Cord red blood cells | Direct antiglobulin test.poly specific reagent |
| 46274-7 | Direct antiglobulin test.poly specific reagent [Presence] on Red Blood Cells --post transfusion reaction | Direct antiglobulin test.poly specific reagent^post transfusion reaction |
| 51006-5 | Direct antiglobulin test.unspecified reagent [Presence] on Red Blood Cells | Direct antiglobulin test.XXX reagent |
| 51007-3 | Direct antiglobulin test.unspecified reagent [Presence] on Red Blood Cells --post transfusion | Direct antiglobulin test.XXX reagent^post transfusion |
| 45613-7 | None | Direct care staff believe resident is capable of increased independence in at least some ADLs |
| 35793-9 | Dirithromycin [Susceptibility] by Disk diffusion (KB) | Dirithromycin |
| 35794-7 | Dirithromycin [Susceptibility] by Minimum inhibitory concentration (MIC) | Dirithromycin |
| 35795-4 | Dirithromycin [Susceptibility] | Dirithromycin |
| 7007-8 | Dirithromycin [Susceptibility] by Gradient strip (E-test) | Dirithromycin |
| 30040-0 | Dirofilaria immitis Ab [Units/volume] in Serum | Dirofilaria immitis Ab |
| 30044-2 | Dirofilaria immitis Ab [Titer] in Serum | Dirofilaria immitis Ab |
| 23029-2 | Dirofilaria immitis Ag [Presence] in Blood | Dirofilaria immitis Ag |
| 23710-7 | Dirofilaria immitis Ag [Presence] in Serum by Immunoassay | Dirofilaria immitis Ag |
| 31801-4 | Dirofilaria immitis Ag [Presence] in Serum | Dirofilaria immitis Ag |
| 28090-9 | None | Disabled family coping |
| 7282-7 | Discase IgE Ab [Units/volume] in Serum | Discase Ab.IgE |
| 28622-9 | Nurse hospital discharge assessment | Discharge assessment note |
| 52525-3 | None | Discharge date |
| 42344-2 | None | Discharge diet |
| 46579-9 | None | Discharge disposition |
| 42345-9 | None | Discharge functional status |
| 28574-2 | Provider-unspecified hospital discharge summary | Discharge note |
| 46069-1 | None | Discharge potential |
| 46068-3 | None | Discharge potential and overall status section |
| 11490-0 | Physician hospital discharge summary | Discharge summarization note |
| 18842-5 | Hospital discharge history (narrative) | Discharge summarization note |
| 28655-9 | Attending physician discharge summary | Discharge summarization note |
| 29761-4 | Dentist hospital discharge summary | Discharge summarization note |
| 34105-7 | None | Discharge summarization note |
| 34106-5 | None | Discharge summarization note |
| 34745-0 | None | Discharge summarization note |
| 46475-0 | None | Discharge support services or assistance |
| 46582-3 | None | Discharge, transfer, death date |
| 18593-4 | Ambulance transport, discharged from originating facility on transfer | Discharged from origin institution |
| 46500-5 | None | Discipline of person completing assessment |
| 46018-8 | None | Disease or condition diagnoses section |
| 46152-5 | None | Diseases (quarterly RUG-III 97 update) |
| 46150-9 | None | Diseases (quarterly RUG-III) |
| 54117-7 | None | Diseases history panel |
| 54137-5 | None | Diseases history panel |
| 46019-6 | None | Diseases or conditions |
| 13107-8 | None | Disialylganglioside GD1a Ab |
| 31344-5 | Disialylganglioside GD1a Ab [Units/volume] in Serum | Disialylganglioside GD1a Ab |
| 44740-9 | Disialylganglioside GD1a Ab [Presence] in Serum | Disialylganglioside GD1a Ab |
| 40819-5 | Disialylganglioside GD1a IgM Ab [Units/volume] in Serum | Disialylganglioside GD1a Ab.IgM |
| 13102-9 | None | Disialylganglioside GD1b Ab |
| 13109-4 | None | Disialylganglioside GD1b Ab |
| 31345-2 | Disialylganglioside GD1b Ab [Units/volume] in Serum | Disialylganglioside GD1b Ab |
| 39586-3 | Disialylganglioside GD1b Ab [Titer] in Serum | Disialylganglioside GD1b Ab |
| 44741-7 | Disialylganglioside GD1b Ab [Presence] in Serum | Disialylganglioside GD1b Ab |
| 13103-7 | None | Disialylganglioside GD1b Ab.IgG |
| 30329-7 | Disialylganglioside GD1b IgG Ab [Titer] in Serum | Disialylganglioside GD1b Ab.IgG |
| 31346-0 | Disialylganglioside GD1b IgG Ab [Units/volume] in Serum | Disialylganglioside GD1b Ab.IgG |
| 44742-5 | Disialylganglioside GD1b IgG Ab [Presence] in Serum | Disialylganglioside GD1b Ab.IgG |
| 13104-5 | None | Disialylganglioside GD1b Ab.IgM |
| 30330-5 | Disialylganglioside GD1b IgM Ab [Titer] in Serum | Disialylganglioside GD1b Ab.IgM |
| 31347-8 | Disialylganglioside GD1b IgM Ab [Units/volume] in Serum | Disialylganglioside GD1b Ab.IgM |
| 44743-3 | Disialylganglioside GD1b IgM Ab [Presence] in Serum | Disialylganglioside GD1b Ab.IgM |
| 12366-1 | Disopyramide [Presence] in Urine | Disopyramide |
| 13558-2 | Disopyramide [Presence] in Serum or Plasma | Disopyramide |
| 14702-5 | Disopyramide [Molecules/volume] in Serum or Plasma | Disopyramide |
| 16780-9 | Disopyramide [Mass/volume] in Urine | Disopyramide |
| 29217-7 | Disopyramide [Mass/volume] in Body fluid | Disopyramide |
| 29401-7 | Disopyramide [Mass/volume] in Gastric fluid | Disopyramide |
| 3576-6 | Disopyramide [Mass/volume] in Serum or Plasma | Disopyramide |
| 4228-3 | Disopyramide [Mass] of Dose | Disopyramide |
| 28381-2 | None | Disorientation |
| 28868-8 | None | Dispenser code |
| 28869-6 | None | Dispenser text |
| 43165-0 | Dissolved solids [Mass/volume] in Water | Dissolved solids |
| 51996-7 | Ambulance transport, distance and time transported information (composite) | Distance and time transported information |
| 28734-2 | None | Distance comment |
| 28735-9 | None | Distance comment |
| 33748-5 | None | Distance from anal verge |
| 33749-3 | None | Distance from anal verge unknown |
| 28848-0 | None | Distance N.binocular |
| 33752-7 | None | Distance of carcinoma from closest lateral margin |
| 33755-0 | None | Distance of carcinoma from deep margin |
| 44685-6 | None | Distance of invasive melanoma to closest deep margin |
| 44683-1 | None | Distance of invasive melanoma to closest lateral margin |
| 44684-9 | None | Distance of melanoma in situ to closest lateral margin |
| 33737-8 | None | Distance of tumor from closest margin |
| 28738-3 | None | Distance signs |
| 28739-1 | None | Distance signs |
| 28740-9 | None | Distance signs.binocular |
| 15510-1 | Ambulance transport, distance transported | Distance transported |
| 51997-5 | Ambulance transport, distance and time transported information - loaded indicator | Distance transported - loaded indicator |
| 21907-1 | None | Distant metastases.clinical |
| 21913-9 | None | Distant metastases.other |
| 21901-4 | None | Distant metastases.pathology |
| 44667-4 | None | Distant metastasis site |
| 6238-0 | Salt grass IgE Ab [Units/volume] in Serum | Distichlis spicata Ab.IgE |
| 15752-9 | Salt grass IgE Ab RAST class in Serum | Distichlis spicata Ab.IgE.RAST class |
| 45436-3 | None | Distinct food preferences |
| 52864-6 | None | District catchment area |
| 45230-0 | None | District where patient entered HIV Rx |
| 16781-7 | Disulfiram [Presence] in Urine | Disulfiram |
| 3577-4 | Disulfiram [Mass/volume] in Serum or Plasma | Disulfiram |
| 4229-1 | Disulfiram [Mass] of Dose | Disulfiram |
| 9357-5 | Disulfiram [Mass/volume] in Urine | Disulfiram |
| 28091-7 | None | Disuse syndrome |
| 12288-7 | Diuretics [Identifier] in Urine | Diuretics |
| 32010-1 | Diuretics [Identifier] in Serum or Plasma by Screen method | Diuretics |
| 32676-9 | Diuretics [Mass/volume] in Urine | Diuretics |
| 28092-5 | None | Diversional activity deficit |
| 45699-6 | None | Dizziness or vertigo |
| 21247-2 | DMD gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | DMD gene mutation analysis |
| 50626-1 | DMD gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Narrative | DMD gene mutation analysis |
| 22075-6 | DMD gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal | DMD gene mutations tested for |
| 35375-5 | DMPK gene allele 1 [Presence] in Blood or Tissue by Molecular genetics method | DMPK gene allele 1 |
| 35751-7 | DMPK gene allele 1 CTG repeats [Entitic number] in Blood or Tissue by Molecular genetics method | DMPK gene allele 1.CTG repeats |
| 35374-8 | DMPK gene allele 2 [Presence] in Blood or Tissue by Molecular genetics method | DMPK gene allele 2 |
| 35750-9 | DMPK gene allele 2 CTG repeats [Entitic number] in Blood or Tissue by Molecular genetics method | DMPK gene allele 2.CTG repeats |
| 34727-8 | DMPK gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | DMPK gene mutation analysis |
| 21757-0 | DMPK gene CTG repeats [Presence] in Blood or Tissue by Molecular genetics method | DMPK gene.CTG repeats |
| 35749-1 | DMPK phenotype [Type] in Blood or Tissue by Molecular genetics method | DMPK phenotype |
| 13308-2 | None | DNA |
| 11013-0 | DNA double strand Ab [Titer] in Serum | DNA double strand Ab |
| 11563-4 | None | DNA double strand Ab |
| 12277-0 | DNA double strand Ab [Presence] in Serum by Farr method | DNA double strand Ab |
| 15177-9 | DNA double strand Ab [Units/volume] in Body fluid | DNA double strand Ab |
| 16782-5 | None | DNA double strand Ab |
| 31348-6 | DNA double strand Ab [Presence] in Serum | DNA double strand Ab |
| 32677-7 | DNA double strand Ab [Units/volume] in Serum by Immunoassay | DNA double strand Ab |
| 34187-5 | DNA double strand Ab [Titer] in Serum by IF Crithidia luciliae | DNA double strand Ab |
| 37993-3 | DNA double strand Ab [Mass/volume] in Serum by Radioimmunoassay (RIA) | DNA double strand Ab |
| 42200-6 | DNA double strand Ab [Units/volume] in Serum by Radioimmunoassay (RIA) | DNA double strand Ab |
| 47299-3 | DNA double strand Ab [Units/volume] in Serum by Farr method | DNA double strand Ab |
| 48308-1 | DNA double strand Ab [Units/volume] in Body fluid by Farr method | DNA double strand Ab |
| 5130-0 | DNA double strand Ab [Units/volume] in Serum | DNA double strand Ab |
| 5131-8 | DNA double strand Ab [Presence] in Serum by Immunofluorescence | DNA double strand Ab |
| 53148-3 | DNA double strand Ab [Presence] in Body fluid | DNA double strand Ab |
| 6457-6 | DNA double strand Ab [Presence] in Serum by IF Crithidia luciliae | DNA double strand Ab |
| 33799-8 | DNA double strand IgG Ab [Units/volume] in Serum by Immunoassay | DNA double strand Ab.IgG |
| 33800-4 | DNA double strand IgG Ab [Units/volume] in Serum | DNA double strand Ab.IgG |
| 30912-0 | DNA index in Unspecified specimen by Flow cytometry (FC) | DNA index |
| 34975-3 | DNA index in Serum or Plasma by Flow cytometry (FC) | DNA index |
| 34973-8 | DNA index 2 in Serum or Plasma by Flow cytometry (FC) | DNA index 2 |
| 34976-1 | DNA index 2 in Unspecified specimen by Flow cytometry (FC) | DNA index 2 |
| 34972-0 | DNA index 3 in Unspecified specimen by Flow cytometry (FC) | DNA index 3 |
| 34974-6 | DNA index 3 in Serum or Plasma by Flow cytometry (FC) | DNA index 3 |
| 48004-6 | DNA marker [Finding] in Blood or Tissue by Molecular genetics method | DNA marker |
| 53043-6 | DNA marker analysis test coverage panel in Blood or Tissue by Molecular genetics method | DNA marker analysis test coverage panel |
| 53035-2 | DNA marker assessed [Identifier] in Blood or Tissue by Molecular genetics method | DNA marker assessed |
| 53042-8 | DNA marker assessed panel in Blood or Tissue by Molecular genetics method | DNA marker assessed panel |
| 53044-4 | DNA marker identified panel in Blood or Tissue by Molecular genetics method | DNA marker identified panel |
| 48003-8 | DNA marker identifier [Identifier] in Blood or Tissue by Molecular genetics method | DNA marker identifier |
| 47998-0 | DNA marker interpretation short name [Text] in Blood or Tissue by Molecular genetics method Narrative | DNA marker interpretation short name |
| 51960-3 | DNA marker results panel in Blood or Tissue by Molecular genetics method | DNA marker results panel |
| 48019-4 | DNA marker type in Blood or Tissue by Molecular genetics method | DNA marker type |
| 30911-2 | DNA ploidy [Identifier] in Unspecified specimen by Flow cytometry (FC) Nominal | DNA ploidy |
| 30917-9 | DNA ploidy [interpretation] in Unspecified specimen by Flow cytometry (FC) Narrative | DNA ploidy |
| 51956-1 | DNA region analysis test coverage panel in Blood or Tissue by Molecular genetics method | DNA region analysis test coverage panel |
| 47999-8 | DNA region name [Identifier] in Blood or Tissue by Molecular genetics method | DNA region name |
| 51959-5 | DNA region of interest [Identifier] in Blood or Tissue by Molecular genetics method | DNA region of interest |
| 53041-0 | DNA region of interest panel in Blood or Tissue by Molecular genetics method | DNA region of interest panel |
| 5132-6 | DNA single strand Ab [Units/volume] in Serum | DNA single strand Ab |
| 10360-6 | DNA single strand IgG Ab [Units/volume] in Serum | DNA single strand Ab.IgG |
| 42201-4 | DNA single strand IgG Ab [Units/volume] in Serum by Immunoassay | DNA single strand Ab.IgG |
| 10361-4 | DNA single strand IgM Ab [Units/volume] in Serum | DNA single strand Ab.IgM |
| 53855-3 | DNAI1+DNAH5 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | DNAI1+DNAH5 gene mutation analysis |
| 14207-5 | Streptococcal DNAse B [Titer] in Serum | DNAse B Ab.Streptococcal |
| 5133-4 | Streptococcal DNAse B [Units/volume] in Serum | DNAse B Ab.Streptococcal |
| 48538-3 | None | Do you enjoy getting up in the morning |
| 48532-6 | None | Do you feel full of energy |
| 48520-1 | None | Do you feel happy most of the time |
| 48528-4 | None | Do you feel pretty worthless the way you are now |
| 48514-4 | None | Do you feel that your life is empty |
| 48533-4 | None | Do you feel that your situation is hopeless |
| 48525-0 | None | Do you feel you have more problems with memory than most |
| 48530-0 | None | Do you find life very exciting |
| 48536-7 | None | Do you frequently feel like crying |
| 48535-9 | None | Do you frequently get upset over little things |
| 48524-3 | None | Do you frequently worry about the future |
| 48537-5 | None | Do you have trouble concentrating |
| 48527-6 | None | Do you often feel downhearted and blue |
| 48521-9 | None | Do you often feel helpless |
| 48515-1 | None | Do you often get bored |
| 48522-7 | None | Do you often get restless and fidgety |
| 48539-1 | None | Do you prefer to avoid social gatherings |
| 48523-5 | None | Do you prefer to stay at home, rather than going out and doing new things |
| 48526-8 | None | Do you think it is wonderful to be alive now |
| 48534-2 | None | Do you think that most people are better off than you are |
| 48529-2 | None | Do you worry a lot about the past |
| 21248-0 | Dobutamine [Mass/volume] in Serum or Plasma | Dobutamine |
| 35174-2 | Docosahexaenoate (C22:6w3) [Molecules/volume] in Serum or Plasma | Docosahexaenoate |
| 35180-9 | Docosapentaenate (C22:5w3) [Molecules/volume] in Serum or Plasma | Docosapentaenate w3 |
| 35181-7 | Docosapentaenate (C22:5w6) [Molecules/volume] in Serum or Plasma | Docosapentaenate w6 |
| 48371-9 | Docosapentaenoate (C22:5 n-3) [Molecules/volume] in Serum or Plasma | Docosapentaenoate |
| 35182-5 | Docosatetraenoate (C22:4w6) [Molecules/volume] in Serum or Plasma | Docosatetraenoate |
| 35160-1 | Docosenoate (C22:1) [Molecules/volume] in Serum or Plasma | Docosenoate |
| 53109-5 | Docosenoate (C22:1)/Creatinine [Molecular ratio] in Urine | Docosenoate/Creatinine |
| 13732-3 | Dodecanedioate/Creatinine [Mass ratio] in Urine | Dodecanedioate/Creatinine |
| 25097-7 | Dodecanedioate/Creatinine [Molecular ratio] in Urine | Dodecanedioate/Creatinine |
| 18455-6 | Dodecanoylcarnitine (C12) [Mass/volume] in Serum or Plasma | Dodecanoylcarnitine (C12) |
| 30331-3 | Dodecanoylcarnitine (C12) [Molecules/volume] in Serum or Plasma | Dodecanoylcarnitine (C12) |
| 45199-7 | Dodecanoylcarnitine (C12) [Molecules/volume] in Blood dot (filter paper) | Dodecanoylcarnitine (C12) |
| 53058-4 | Dodecanoylcarnitine (C12) [Molecules/volume] in Amniotic Fluid | Dodecanoylcarnitine (C12) |
| 53078-2 | Dodecanoylcarnitine (C12) [Molecules/volume] in Cerebral spinal fluid | Dodecanoylcarnitine (C12) |
| 53510-4 | Dodecanoylcarnitine (C12)/Creatinine [Molecular ratio] in Urine | Dodecanoylcarnitine (C12)/Creatinine |
| 49939-2 | Dodecenedioate/Creatinine [Molecular ratio] in Urine | Dodecenedioate/Creatinine |
| 18454-9 | Dodecenoylcarnitine (C12:1) [Mass/volume] in Serum or Plasma | Dodecenoylcarnitine (C12:1) |
| 30332-1 | Dodecenoylcarnitine (C12:1) [Molecules/volume] in Serum or Plasma | Dodecenoylcarnitine (C12:1) |
| 45200-3 | Dodecenoylcarnitine (C12:1) [Molecules/volume] in Blood dot (filter paper) | Dodecenoylcarnitine (C12:1) |
| 53059-2 | Dodecenoylcarnitine (C12:1) [Molecules/volume] in Amniotic Fluid | Dodecenoylcarnitine (C12:1) |
| 53079-0 | Dodecenoylcarnitine (C12:1) [Molecules/volume] in Cerebral spinal fluid | Dodecenoylcarnitine (C12:1) |
| 53104-6 | Dodecenoylcarnitine (C12:1) [Molecules/volume] in Urine | Dodecenoylcarnitine (C12:1) |
| 53511-2 | Dodecenoylcarnitine (C12:1)/Creatinine [Molecular ratio] in Urine | Dodecenoylcarnitine (C12:1)/Creatinine |
| 53542-7 | Dodeicosanoylcarnitine (C22) [Molecules/volume] in Amniotic Fluid | Dodeicosanoylcarnitine (C22) |
| 53543-5 | Dodeicosanoylcarnitine (C22) [Molecules/volume] in Blood dot (filter paper) | Dodeicosanoylcarnitine (C22) |
| 53545-0 | Dodeicosanoylcarnitine (C22) [Molecules/volume] in Cerebral spinal fluid | Dodeicosanoylcarnitine (C22) |
| 53546-8 | Dodeicosanoylcarnitine (C22) [Molecules/volume] in Serum or Plasma | Dodeicosanoylcarnitine (C22) |
| 53549-2 | Dodeicosanoylcarnitine (C22) [Molecules/volume] in Urine | Dodeicosanoylcarnitine (C22) |
| 53552-6 | Dodeicosanoylcarnitine (C22)/Creatinine [Molecular ratio] in Urine | Dodeicosanoylcarnitine (C22)/Creatinine |
| 45582-4 | None | Does not adjust easily to change in routines |
| 6098-8 | Dog dander IgE Ab [Units/volume] in Serum | Dog dander Ab.IgE |
| 15685-1 | Dog dander IgE Ab RAST class in Serum | Dog dander Ab.IgE.RAST class |
| 7284-3 | Dog dander IgG Ab [Units/volume] in Serum | Dog dander Ab.IgG |
| 41272-6 | Dog dander+Dog epithelium IgE Ab RAST class in Serum | Dog dander+Dog epithelium Ab.IgE.RAST class |
| 6099-6 | Dog epithelium IgE Ab [Units/volume] in Serum | Dog epithelium Ab.IgE |
| 15686-9 | Dog epithelium IgE Ab RAST class in Serum | Dog epithelium Ab.IgE.RAST class |
| 7285-0 | Dog epithelium IgG Ab [Units/volume] in Serum | Dog epithelium Ab.IgG |
| 7286-8 | Dog epithelium triggered histamine release [Units/volume] in Blood | Dog epithelium basophil bound Ab |
| 48229-9 | Dog epithelium triggered leukotriene release [Mass/volume] by Leukocytes | Dog epithelium leukotriene release |
| 19738-4 | Dog serum albumin IgE Ab [Units/volume] in Serum | Dog serum albumin Ab.IgE |
| 25395-5 | Dog serum albumin IgE Ab RAST class in Serum | Dog serum albumin Ab.IgE.RAST class |
| 7288-4 | Dogwood pollen IgE Ab [Units/volume] in Serum | Dogwood pollen Ab.IgE |
| 7792-5 | Dohle body [Presence] in Blood by Light microscopy | Dohle body |
| 12606-0 | Dolichol [Mass/volume] in Serum or Plasma | Dolichol |
| 21249-8 | Dolichol [Mass/volume] in Urine | Dolichol |
| 39544-2 | Yellow Hornet IgE Ab [Ratio] in Serum | Dolichovespula arenaria Ab.IgE |
| 6288-5 | Yellow Hornet IgE Ab [Units/volume] in Serum | Dolichovespula arenaria Ab.IgE |
| 15783-4 | Yellow Hornet IgE Ab RAST class in Serum | Dolichovespula arenaria Ab.IgE.RAST class |
| 49740-4 | Yellow Hornet IgG Ab [Mass/volume] in Serum | Dolichovespula arenaria Ab.IgG |
| 6739-7 | Yellow Hornet IgG Ab [Units/volume] in Serum | Dolichovespula arenaria Ab.IgG |
| 41192-6 | Yellow Hornet IgG4 Ab [Presence] in Serum | Dolichovespula arenaria Ab.IgG4 |
| 6280-2 | Whitefaced Hornet IgE Ab [Units/volume] in Serum | Dolichovespula maculata Ab.IgE |
| 15782-6 | Whitefaced Hornet IgE Ab RAST class in Serum | Dolichovespula maculata Ab.IgE.RAST class |
| 49745-3 | Whitefaced Hornet IgG Ab [Mass/volume] in Serum | Dolichovespula maculata Ab.IgG |
| 7417-9 | Whitefaced Hornet IgG Ab [Units/volume] in Serum | Dolichovespula maculata Ab.IgG |
| 44315-0 | Whitefaced Hornet IgG Ab RAST class in Serum | Dolichovespula maculata Ab.IgG.RAST class |
| 41193-4 | Whitefaced Hornet IgG4 Ab [Presence] in Serum | Dolichovespula maculata Ab.IgG4 |
| 44658-3 | None | Dominant nodule.additional dimension 1 |
| 44659-1 | None | Dominant nodule.additional dimension 2 |
| 44657-5 | None | Dominant nodule.max.dimension |
| 51418-2 | Domperidone [Molecules/volume] in Body fluid | Domperidone |
| 51442-2 | Domperidone [Molecules/volume] in Serum or Plasma | Domperidone |
| 28368-9 | None | Don't have to keep fighting |
| 28367-1 | None | Don't want high technology to keep me alive |
| 53948-6 | Donated egg [Presence] | Donated egg |
| 18286-5 | Donath Landsteiner Ab [Presence] in Blood | Donath Landsteiner Ab |
| 18287-3 | Donath Landsteiner Ab [Presence] in Serum & RBC from control | Donath Landsteiner Ab |
| 18288-1 | Donath Landsteiner Ab [Titer] in Serum & RBC from control | Donath Landsteiner Ab |
| 48817-1 | Donath Landsteiner Ab [Titer] in Serum from control | Donath Landsteiner Ab |
| 51979-3 | Donepezil [Mass/volume] in Serum or Plasma | Donepezil |
| 3143-5 | None | Donor relation to patient |
| 14703-3 | Dopamine [Molecules/volume] in Serum or Plasma | Dopamine |
| 15058-1 | Dopamine [Molecules/volume] in Urine | Dopamine |
| 15059-9 | Dopamine [Molecules/time] in 24 hour Urine | Dopamine |
| 2216-0 | Dopamine [Mass/volume] in Serum or Plasma | Dopamine |
| 2217-8 | Dopamine [Mass/volume] in Urine | Dopamine |
| 2218-6 | Dopamine [Mass/time] in 24 hour Urine | Dopamine |
| 25906-9 | Dopamine [Molecules/volume] in 24 hour Urine | Dopamine |
| 27212-0 | Dopamine [Mass/volume] in 24 hour Urine | Dopamine |
| 2219-4 | Dopamine beta-hydroxylase [Enzymatic activity/volume] in Serum or Plasma | Dopamine beta-hydroxylase |
| 13733-1 | Dopamine/Creatinine [Mass ratio] in Urine | Dopamine/Creatinine |
| 24524-1 | Dopamine/Creatinine [Molecular ratio] in Urine | Dopamine/Creatinine |
| 33873-1 | Dopamine/Creatinine [Molecular ratio] in unspecified time Urine | Dopamine/Creatinine |
| 44316-8 | Dopamine/Creatinine [Mass ratio] in 24 hour Urine | Dopamine/Creatinine |
| 44918-1 | Dopamine/Creatinine [Molecular ratio] in 24 hour Urine | Dopamine/Creatinine |
| 27443-1 | Dopamine [Mass/volume] in Serum or Plasma --1 hour post XXX challenge | Dopamine^1H post XXX challenge |
| 27348-2 | Dopamine [Mass/volume] in Serum or Plasma --2 hours post XXX challenge | Dopamine^2H post XXX challenge |
| 13432-0 | Dopamine [Mass/volume] in Serum or Plasma --2nd specimen post XXX challenge | Dopamine^2nd specimen post XXX challenge |
| 16784-1 | Dopamine [Mass/volume] in Urine --2nd specimen post XXX challenge | Dopamine^2nd specimen post XXX challenge |
| 27363-1 | Dopamine [Mass/volume] in Serum or Plasma --3 hours post XXX challenge | Dopamine^3H post XXX challenge |
| 13433-8 | Dopamine [Mass/volume] in Serum or Plasma --3rd specimen post XXX challenge | Dopamine^3rd specimen post XXX challenge |
| 16785-8 | Dopamine [Mass/volume] in Urine --3rd specimen post XXX challenge | Dopamine^3rd specimen post XXX challenge |
| 27380-5 | Dopamine [Mass/volume] in Serum or Plasma --4 hours post XXX challenge | Dopamine^4H post XXX challenge |
| 13434-6 | Dopamine [Mass/volume] in Serum or Plasma --4th specimen post XXX challenge | Dopamine^4th specimen post XXX challenge |
| 16786-6 | Dopamine [Mass/volume] in Urine --4th specimen post XXX challenge | Dopamine^4th specimen post XXX challenge |
| 13435-3 | Dopamine [Mass/volume] in Serum or Plasma --5th specimen post XXX challenge | Dopamine^5th specimen post XXX challenge |
| 16787-4 | Dopamine [Mass/volume] in Urine --5th specimen post XXX challenge | Dopamine^5th specimen post XXX challenge |
| 13436-1 | Dopamine [Mass/volume] in Serum or Plasma --6th specimen post XXX challenge | Dopamine^6th specimen post XXX challenge |
| 16788-2 | Dopamine [Mass/volume] in Urine --6th specimen post XXX challenge | Dopamine^6th specimen post XXX challenge |
| 13437-9 | Dopamine [Mass/volume] in Serum or Plasma --7th specimen post XXX challenge | Dopamine^7th specimen post XXX challenge |
| 16789-0 | Dopamine [Mass/volume] in Urine --7th specimen post XXX challenge | Dopamine^7th specimen post XXX challenge |
| 34068-7 | None | Dosage & administration section |
| 43678-2 | None | Dosage forms and strengths section |
| 52809-1 | None | Dose form |
| 30973-2 | None | Dose number |
| 29652-5 | Dothiepin [Mass/volume] in Serum or Plasma | Dothiepin |
| 29653-3 | Dothiepin [Molecules/volume] in Serum or Plasma | Dothiepin |
| 35120-5 | Dothiepin sulfoxide [Mass/volume] in Serum or Plasma | Dothiepin sulfoxide |
| 45422-3 | None | Down's syndrome |
| 10985-0 | Doxapram [Mass/volume] in Serum or Plasma | Doxapram |
| 14704-1 | Doxepin [Presence] in Gastric fluid | Doxepin |
| 14705-8 | Doxepin [Molecules/volume] in Serum or Plasma | Doxepin |
| 14706-6 | Doxepin [Molecules/volume] in Urine | Doxepin |
| 16115-8 | Doxepin [Mass/mass] in Tissue | Doxepin |
| 29410-8 | Doxepin [Mass/volume] in Gastric fluid | Doxepin |
| 35609-7 | Doxepin [Mass/volume] in Serum or Plasma by Screen method | Doxepin |
| 3578-2 | Doxepin [Presence] in Serum or Plasma | Doxepin |
| 3579-0 | Doxepin [Mass/volume] in Serum or Plasma | Doxepin |
| 3580-8 | Doxepin [Presence] in Urine | Doxepin |
| 3581-6 | Doxepin [Mass/volume] in Urine | Doxepin |
| 40629-8 | Doxepin [Presence] in Unspecified specimen | Doxepin |
| 4230-9 | Doxepin [Mass] of Dose | Doxepin |
| 47104-5 | Doxepin [Molecules/volume] in Gastric fluid | Doxepin |
| 43122-1 | Doxepin & Nordoxepin panel [Mass/volume] in Serum or Plasma | Doxepin & Nordoxepin panel |
| 16790-8 | None | Doxepin+Desmethyldoxepin |
| 19247-6 | Doxepin+Metabolites [Mass/volume] in Urine | Doxepin+Metabolites |
| 3583-2 | Doxepin+Metabolites [Mass/volume] in Serum or Plasma | Doxepin+Metabolites |
| 10537-9 | None | Doxepin+Nordoxepin |
| 14707-4 | Doxepin+Nordoxepin [Molecules/volume] in Serum or Plasma | Doxepin+Nordoxepin |
| 3582-4 | Doxepin+Nordoxepin [Mass/volume] in Serum or Plasma | Doxepin+Nordoxepin |
| 3584-0 | Doxepin [Mass/volume] in Serum or Plasma --trough | Doxepin^trough |
| 13624-2 | Doxorubicin [Mass/volume] in Serum or Plasma | Doxorubicin |
| 10986-8 | Doxycycline [Mass/volume] in Serum or Plasma | Doxycycline |
| 18917-5 | Doxycycline [Susceptibility] | Doxycycline |
| 20379-4 | Doxycycline [Susceptibility] by Method for Slow-growing mycobacteria | Doxycycline |
| 21250-6 | Doxycycline [Mass/volume] in Unspecified specimen | Doxycycline |
| 224-6 | Doxycycline [Susceptibility] by Minimum lethal concentration (MLC) | Doxycycline |
| 225-3 | Doxycycline [Susceptibility] by Minimum inhibitory concentration (MIC) | Doxycycline |
| 226-1 | Doxycycline [Susceptibility] by Disk diffusion (KB) | Doxycycline |
| 227-9 | Doxycycline [Susceptibility] by Serum bactericidal titer | Doxycycline |
| 23623-2 | None | Doxycycline |
| 26902-7 | Doxycycline [Units/volume] in Unspecified specimen | Doxycycline |
| 7008-6 | Doxycycline [Susceptibility] by Gradient strip (E-test) | Doxycycline |
| 25223-9 | Doxycycline 30 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria | Doxycycline 30.0 ug/mL |
| 16791-6 | Doxylamine [Mass/volume] in Serum or Plasma | Doxylamine |
| 16792-4 | Doxylamine [Mass/volume] in Urine | Doxylamine |
| 3585-7 | Doxylamine [Presence] in Serum or Plasma | Doxylamine |
| 3586-5 | Doxylamine [Presence] in Urine | Doxylamine |
| 4231-7 | Doxylamine [Mass] of Dose | Doxylamine |
| 28883-7 | None | Doz.inside |
| 28906-6 | None | Doz.inside |
| 28934-8 | None | Doz.inside |
| 28961-1 | None | Doz.inside |
| 28884-5 | None | Doz.outside |
| 28907-4 | None | Doz.outside |
| 28935-5 | None | Doz.outside |
| 28962-9 | None | Doz.outside |
| 18034-9 | None | dP/dT (1 M/S to 3 M/S).systole |
| 18035-6 | None | dP/dT (1M/S to 3 M/S) |
| 45284-7 | DPYD gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | DPYD gene mutation analysis |
| 39116-9 | None | Drainage amount |
| 39115-1 | None | Drainage description |
| 28409-1 | None | Dressing |
| 39121-9 | None | Dressing |
| 28093-3 | None | Dressing &or grooming deficit |
| 45600-4 | None | Dressing - self-performance |
| 45601-2 | None | Dressing - support provided |
| 53245-7 | None | Driver license image attachment |
| 16144-8 | Droperidol [Presence] in Serum or Plasma | Droperidol |
| 34074-5 | None | Drug &or laboratory test interactions section |
| 42831-8 | None | Drug abuse |
| 42227-9 | None | Drug abuse and dependence section |
| 53975-9 | Drug crystals [Presence] in Urine sediment by Light microscopy | Drug crystals |
| 51964-5 | Drug efficacy analysis overall interpretation [interpretation] in Blood or Tissue by Molecular genetics method | Drug efficacy analysis overall interpretation |
| 51961-1 | Drug efficacy marker interpretation [interpretation] in Blood or Tissue Qualitative by Molecular genetics method | Drug efficacy marker interpretation |
| 34073-7 | None | Drug interactions section |
| 52570-9 | None | Drug list is complete |
| 51971-0 | Drug metabolism analysis overall interpretation [interpretation] in Blood or Tissue by Molecular genetics method | Drug metabolism analysis overall interpretation |
| 53040-2 | Drug metabolism marker interpretation [interpretation] in Blood or Tissue by Molecular genetics method | Drug metabolism marker interpretation |
| 39245-6 | None | Drug or alcohol abuse counselled |
| 12286-1 | Drugs identified in Urine by Screen method | Drugs identified |
| 12287-9 | Drugs identified in Gastric fluid by Screen method | Drugs identified |
| 12289-5 | Drugs identified in Vitreous fluid by Screen method | Drugs identified |
| 15401-3 | Drugs identified in Blood by Screen method | Drugs identified |
| 16793-2 | Drugs identified in Unknown substance by Screen method | Drugs identified |
| 20785-2 | Drugs identified in Serum or Plasma by Screen method | Drugs identified |
| 20786-0 | Drugs identified in Tissue by Screen method | Drugs identified |
| 20787-8 | Drugs identified in Unspecified specimen by Screen method | Drugs identified |
| 27034-8 | Drugs identified in Hair by Screen method | Drugs identified |
| 27208-8 | Drugs identified in Stool by Screen method | Drugs identified |
| 32797-3 | Drugs identified in Meconium by Screen method | Drugs identified |
| 34601-5 | Drugs identified in Body fluid | Drugs identified |
| 40464-0 | Drugs identified in Urine by Confirm method | Drugs identified |
| 40585-2 | Drugs identified in Unspecified specimen by Confirm method | Drugs identified |
| 41270-0 | Drugs identified in Urine | Drugs identified |
| 42326-9 | Drugs identified in Mother's Milk by Screen method | Drugs identified |
| 24349-3 | Drugs of abuse 5 panel in Urine | Drugs of abuse 5 panel |
| 51782-1 | Drugs of abuse 9 panel in Urine | Drugs of abuse 9 panel |
| 49046-6 | Drugs of abuse panel in Meconium | Drugs of abuse panel |
| 28382-0 | None | Dry mouth |
| 23030-0 | Duck enteritis virus [Presence] in Tissue by Electron microscopy | Duck enteritis virus |
| 20788-6 | Duck enteritis virus Ab [Presence] in Serum by Neutralization test | Duck enteritis virus Ab |
| 22254-7 | Duck enteritis virus Ab [Presence] in Serum | Duck enteritis virus Ab |
| 43328-4 | Duck enteritis virus Ab [Presence] in Serum by Immunofluorescence | Duck enteritis virus Ab |
| 20852-0 | Duck enteritis virus Ag [Units/mass] in Tissue Qualitative by Immunofluorescence | Duck enteritis virus Ag |
| 23031-8 | Duck enteritis virus Ag [Presence] in Unspecified specimen by Neutralization test | Duck enteritis virus Ag |
| 23032-6 | Duck enteritis virus Ag [Presence] in Unspecified specimen by Agglutination | Duck enteritis virus Ag |
| 31802-2 | Duck enteritis virus Ag [Presence] in Unspecified specimen | Duck enteritis virus Ag |
| 6100-2 | Duck feather IgE Ab [Units/volume] in Serum | Duck feather Ab.IgE |
| 15687-7 | Duck feather IgE Ab RAST class in Serum | Duck feather Ab.IgE.RAST class |
| 7289-2 | Duck feather IgG Ab [Units/volume] in Serum | Duck feather Ab.IgG |
| 23033-4 | Duck hepatitis virus 1 Ab [Presence] in Serum by Neutralization test | Duck hepatitis virus 1 Ab |
| 23034-2 | Duck hepatitis virus 1 Ab [Presence] in Serum | Duck hepatitis virus 1 Ab |
| 23035-9 | Duck hepatitis virus 1 Ag [Presence] in Unspecified specimen by Neutralization test | Duck hepatitis virus 1 Ag |
| 31803-0 | Duck hepatitis virus 1 Ag [Presence] in Unspecified specimen | Duck hepatitis virus 1 Ag |
| 23036-7 | Duck hepatitis virus 2 Ab [Presence] in Serum | Duck hepatitis virus 2 Ab |
| 23037-5 | Duck hepatitis virus 2 Ab [Presence] in Serum by Neutralization test | Duck hepatitis virus 2 Ab |
| 23038-3 | Duck hepatitis virus 2 Ag [Presence] in Unspecified specimen by Neutralization test | Duck hepatitis virus 2 Ag |
| 31804-8 | Duck hepatitis virus 2 Ag [Presence] in Unspecified specimen | Duck hepatitis virus 2 Ag |
| 23039-1 | Duck hepatitis virus 3 Ab [Presence] in Serum | Duck hepatitis virus 3 Ab |
| 23040-9 | Duck hepatitis virus 3 Ab [Presence] in Serum by Neutralization test | Duck hepatitis virus 3 Ab |
| 23041-7 | Duck hepatitis virus 3 Ag [Presence] in Unspecified specimen by Immunofluorescence | Duck hepatitis virus 3 Ag |
| 31805-5 | Duck hepatitis virus 3 Ag [Presence] in Unspecified specimen | Duck hepatitis virus 3 Ag |
| 6101-0 | Duck meat IgE Ab [Units/volume] in Serum | Duck meat Ab.IgE |
| 25396-3 | Duck meat IgE Ab RAST class in Serum | Duck meat Ab.IgE.RAST class |
| 13309-0 | Duffy group Ag [Type] on Red Blood Cells | Duffy group Ag |
| 46227-5 | Duloxetine [Mass/volume] in Serum or Plasma | Duloxetine |
| 21960-0 | None | Duration |
| 10572-6 | None | Duration^post ejaculation |
| 6102-8 | None | Dust profile Ab.IgE |
| 21969-1 | None | Dx &or stage |
| 21861-0 | None | Dx confirmed by |
| 28094-1 | None | Dying process |
| 3587-3 | Dyphylline [Mass/volume] in Serum or Plasma | Dyphylline |
| 4232-5 | Dyphylline [Mass] of Dose | Dyphylline |
| 32653-8 | DYS gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | DYS gene mutation analysis |
| 46992-4 | DYS gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Narrative | DYS gene mutation analysis |
| 43745-9 | DYS gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal | DYS gene mutations tested for |
| 51589-0 | Dyserythropoiesis [Presence] in Blood by Light microscopy | Dyserythropoiesis |
| 53856-1 | DYSF gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Narrative | DYSF gene mutation analysis |
| 35124-7 | Dysferlin [Presence] in Leukocytes | Dysferlin |
| 28095-8 | None | Dysfunctional grieving |
| 34489-5 | DYT1 gene deletion [Presence] in Blood or Tissue by Molecular genetics method | DYT1 gene deletion |
| 34495-2 | DYT1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Narrative | DYT1 gene mutation analysis |
| 38411-5 | DYT1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | DYT1 gene mutation analysis |